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Periodontal disease is a bacteria-induced inflammatory disease resulting in the 
destruction of the tooth’s attaching apparatus (the periodontium). Oral 
streptococci predominate during periodontal health while gram-negative 
anaerobes increase in amounts in the subgingival plaque of patients with 
periodontal disease.  
 
Patients with periodontal disease often suffer from oral malodour or halitosis. 
Halitosis is attributed to the production of volatile sulphur compounds (VSCs) by 
periodontal disease associated bacteria including Fusobacterium nucleatum, 
Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia. These 
bacterial species metabolize sulphur-containing amino acids such as L-cysteine 
and serum proteins to produce VSCs as by-products of anaerobic metabolism. 
Hydrogen sulphide (H2S) is the predominant VSC found in periodontal pockets. 
These periodontal disease associated bacteria produce H2S in abundance. 
However, the potential effects of H2S on periodontal health and diseased-
associated oral flora have not been well studied. We found that H2S protected F. 
nucleatum from oxidative stress induced under aerobic conditions, but elicited 
differential microbicidal effects on different oral streptococci species. H2S from 
F. nucleatum inhibited the growth of Streptococcus mitis and S. oralis but not S. 
gordonii and S. sanguinis. This differential susceptibility of H2S on oral 
streptococci was attributed to differences in intracellular concentrations of 
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reduced glutathione (GSH) in these bacterial species. In GSH-deficient S. mitis 
and S. oralis, H2S elicited its toxicity through an iron-dependent mechanism. 
 
In mammalian cells, H2S is an important biological signalling molecule that 
modulates hypertension, inflammation, gastric mucosal integrity, neuronal 
function and vascular tone. Intracellular levels of H2S range from nM to µM 
concentrations. To date, H2S has been shown to elicit either pro- or anti-
inflammatory effects depending on the cell model and concentration of H2S used. 
The concentration of H2S in subgingival plaque has been reported to be up to 2 
mM. However, the effects of H2S on the inflammatory response of cells in the 
periodontium have not been well characterized. Using primary human periodontal 
fibroblasts, we found that H2S alone elicited the production of interleukin-6 (IL-6) 
and interleukin-8 (IL-8). These inflammatory mediators were regulated post-
transcriptionally via p38 mitogen-activated protein kinase (MAPK)-mediated 
signalling. However, H2S suppressed toll-like receptor (TLR)-mediated 
inflammatory response via inhibiting nuclear factor kappa-light-chain-enhancer of 
activated B-cells (NF-κB) by restoring intracellular reduced glutathione (GSH) to 
oxidized glutathione (GSSG) ratio.  
 
Collectively, data obtained from this work provide new insights into the 
multifaceted roles of H2S as a potential bacterial virulence factor in periodontal 
disease, disturbing the microbial homeostasis of plaque biofilm and inflammatory 
response of periodontal fibroblasts in the periodontium.   
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Periodontal disease is a plaque biofilm-induced chronic inflammatory disease that 
occurs in the periodontium which comprises of the gingiva (gum), cementum, 
periodontal ligament and alveolar bone that supports the tooth. Patients with 
periodontal disease exhibit clinical signs of inflammation, detachment and apical 
migration of the junctional epithelium, periodontal pocket formation with 
destruction of periodontal ligament and alveolar bone loss. The deep pocket 
between the tooth and the gum leads to loosening of the tooth and, ultimately, 
tooth loss. Periodontal disease affects up to 40% of the adult population and 
remains the most common cause of tooth loss globally (Eke et al., 2012). Disease 
progression is monitored using a periodontal probe which is placed into the 
gingival sulcus to measure the pocket depth and bleeding indices (Fig. 1.1). 
Probing depth greater than three millimetre is considered to be diseased, and 
bleeding on probing is considered to be a sign of active periodontal disease.  
Patients with pocket depths of seven millimetre or greater around their teeth risk 
eventual tooth loss (Khan et al., 2015). 
 
Although dental plaque is required for the initiation of periodontal disease, host 
inflammatory response to the microbial challenge plays a major role in the 
destruction of the periodontium. While the precise mechanism of periodontal 
pathogenesis is not completely understood, the disease initiation and progression 
involve disturbance of host-microbe homeostasis. The lack of oral hygiene with 
inadequate plaque biofilm control coupled with host and lifestyle factors such as 
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genetic predisposition (Rylev and Kilian, 2008), diabetes (Casanova et al., 2015), 
age (Holm-Pedersen et al., 2015), smoking (Delima et al., 2010) and nutrition 




Figure 1.1. Formation of a periodontal pocket. Accumulation of plaque biofilm 
leads to inflammation of gingival tissues. Junctional epithelium responds to 
healing by migrating to the apex of the tooth. Gingival sulcus deepens leading to 
formation of a periodontal pocket and loss of alveolar bone. Pocket depths are 
measured at 6 sites around a tooth to determine the extent of tissue destruction 
using a periodontal probe. Adapted and modified from Khan, S. A., Kong, E. F., 
Meiller, T. F., & Jabra-Rizk, M. A. (2015). Periodontal Diseases: Bug Induced, 
Host Promoted. PLoS Pathog, 11(7), e1004952. This figure is an open access 






1.2 Role of plaque in the aetiology of periodontal disease  
The surfaces of teeth are the only “non-shedding” surfaces in the oral cavity that 
allow stable microbial colonization. The tooth enamel is coated with salivary 
pellicle, which provides binding sites for colonization of pioneer microbial 
colonizers (Kawashima et al., 2003; Nyvad and Kilian, 1990). The microbial 
community in the supragingival plaque (above the gum line) differs from the 
subgingival (below the gum line) community. The supragingival plaque is 
dominated by gram-positive facultative anaerobes while gram-negative strict 
anaerobes are predominant in the subgingival plaque (Diaz et al., 2006; 
Jakubovics, 2015; Takeshita et al., 2015).  
 
In the 1960’s, a series of small sample size, uncontrolled studies were conducted 
to induce gingival inflammation in humans by abstaining from all efforts of oral 
hygiene procedures. In these studies, accumulation of dental plaque in the study 
volunteers led to gingival inflammation while restoration of oral hygiene resolved 
gingival inflammation (Löe et al., 1965; Theilade et al., 1966). This is in 
agreement with the “non-specific plaque hypothesis” proposed by Miller, 1891 
which states that accumulation of dental plaque, regardless of its composition 
induces gingival inflammation. Following the invention of microbial culture 
techniques and microscopy, microorganisms associated with periodontal disease 
were identified. The notion of “specific plaque hypothesis” (Loesche, 1976) 
which incorporated revised Henle-Koch’s postulates (Evans, 1976) was 
introduced and the idea that periodontal disease is an infectious disease with a 
5 
 
suspected pathogen as a cause of disease was proposed. In 1979, Socransky 
modified the classical Koch’s postulates and instead proposed a modified series of 
criteria for microbial causation of periodontal disease which states that, i) the 
suspected microorganism should be associated with periodontal disease, ii) its 
elimination should reduce the clinical signs of the disease, (iii) there should be 
evidence of a host response to the suspected microorganism, (iv) the suspected 
microorganism should cause disease when inoculated in an animal model, and (v) 
the suspected pathogen should produce virulence factors that contribute to the 
disease process (Socransky, 1979). However, in periodontal disease, several 
putative periodontal pathogens are also found to be present in the plaque biofilm 
of non-diseased subjects, albeit in lower amounts (Hinrichs et al., 1985). In 1998, 
using the DNA-DNA hybridization technique which allows analysis of 40 
different bacterial species simultaneously, the Socransky-microbial complexes 
were proposed based on their association with periodontal disease (Socransky et 
al., 1998) (Fig. 1.2). These microbial complexes are widely used to describe 
groups of periodontal pathogens and their association with periodontal disease. 
The “red complex” bacteria consisted of the gram-negative strict anaerobes 
namely Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola 
which were found to be highly associated with destructive periodontal disease and 
were frequently associated with deep periodontal pockets (Socransky et al., 1998). 
After periodontal treatment, these “red complex” bacteria diminished. When 
inflammation and deep pockets reappeared, the “red complex” again becomes 
prominent. The “orange complex” which consists of Prevotella spp., 
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Fusobacterium spp. and Parvimonas micra appeared to be closely associated with 
the “red complex” bacteria. Notably, Fusobacterium spp. is the dominant member 
in this colour cluster. The “yellow complex” is predominantly made up of 
streptococci which are associated with health. Similarly, species such as 
Actinomyces naeslundii genospecies 2 (A. viscosus) and “green complex” were 
less commonly associated with members of the “red” and “orange complexes” 
than with each other. The two species in the “purple complex” were strongly 
related to each other and to a lesser extent to the members of the “orange”, 
“green” and “yellow complexes”. Selenomonas noxia and 
Aggregatibacter actinomycetemcomitans serotype b are the two outliers which did 
not cluster with other bacterial species.  
 
Figure 1.2. Microbial complexes in subgingival plaque biofilm. Adapted from 
Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C., & Kent, R. L. (1998). 
Microbial complexes in subgingival plaque. Journal of Clinical 
Periodontology, 25(2), 134-144. Figure was obtained from John Wiley and Sons 
with permission (license number 3778041042035). 
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In the early 1990’s, Philip D. Marsh (Marsh, 1994) proposed that the presence of 
nutrients and essential cofactors, pH and redox potential in the microenvironment 
of periodontal pocket influenced bacterial composition in dental microflora 
predisposing a site to disease. In his “ecological plaque hypothesis” (Marsh, 
1994), the outcome of the interactions between plaque biofilm and host response 
is the determining factor between maintenance of health or transition to disease 
state (Fig. 1.3). 
 
 
Figure 1.3. The “ecological plaque hypothesis” in periodontal disease. The host 
mounts an inflammatory response to the microbial challenge from the 
accumulation of plaque around the gingival margin via increasing the flow of 
gingival crevicular fluid (GCF). Consequences of the host inflammatory response 
include degradation of collagen and heme-containing compounds such as 
haptoglobin, hemopexin and hemoglobin that can be used by proteolytic bacteria 
to obtain essential amino acids and iron for growth. Active inflammation leads to 
the migration of the junctional epithelium to the apex of the tooth resulting in the 
formation of a periodontal pocket with reduced oxygen tension allowing 
anaerobes to flourish. Adapted from Marsh, P. D., & Devine, D. A. (2011). How 
is the development of dental biofilms influenced by the host? Journal of Clinical 
Periodontology, 38(s11), 28-35. Figure was obtained from John Wiley and Sons 
with permission (license number 3777951320355). 
8 
 
More recently, the “keystone-pathogen hypothesis” (Hajishengallis et al., 2012) 
which emphasized the importance of P. gingivalis in the pathogenesis of 
periodontal disease was proposed. This hypothesis suggests that low levels of P. 
gingivalis interfere with the host immune system and alter the composition of oral 
microbiota. P. gingivalis impairs host defences via its ability to manipulate Toll-
like receptor (TLR) responses by activating or antagonising TLR4 via its lipid A 
moiety (Darveau, 2010), subverting interleukin-8 (IL-8) release from epithelial 
cells (Darveau et al., 1998) and interfering with the complement system 
(Hajishengallis and Lambris, 2011) that recognises and destroys microorganisms. 
Additionally, P. gingivalis which constitutes <0.01% of the total bacterial count 
in plaque has been demonstrated to alter the plaque composition in mice, leading 
to periodontal disease (Hajishengallis et al., 2011). Of note, in germ-free mice, P. 
gingivalis was able to colonize the oral cavity without eliciting disease. This 
indicates that the presence of commensal microbiota is essential in the disease 
process (Hajishengallis et al., 2011). 
 
With the availability of 16S ribosomal RNA (rRNA)-based Human Oral Microbe 
Identification Microarray (HOMIM), the subgingival microbial profiles of 
periodontal healthy and diseased plaque were compared (Colombo et al., 2009) 
where plaque from patients with periodontal disease showed increase diversity in 
bacterial species. In addition, subgingival plaque from diseased subjects 
harboured significantly higher frequency of putative periodontal pathogens such 
as P. gingivalis, Prevotella spp., T. forsythia, and Treponema spp. Bacterial 
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species that were more prevalent in healthy subjects included Actinomyces spp., 
Capnocytophaga sputigena, Cardiobacterium hominis, Haemophilus 
parainfluenzae, Lautropia mirabilis, Propionibacterium propionicum, Rothia 
dentocariosa/mucilaginosa, and Streptococcus sanguinis. The findings obtained 
from this study suggest that alterations in the relative abundance of bacterial 
species compared to their abundance in health likely lead to breakdown of host-
microbe interactions that contribute to periodontal disease (Hajishengallis, 2014). 
The polymicrobial synergy and dysbiosis (the ‘PSD model’) proposes that the 
disruption of the ecological balance of plaque composition (dysbiosis) leads to the 
synergistic interactions of variable members of the microbial community or their 
specific gene combinations that provoke disease rather than ‘selected’ pathogens. 
With advances in DNA sequencing technology, the entire microbial population of 
subgingival plaque from periodontal health and diseased samples can now be 
characterized. Using pyrosequencing, Griffen et al. reported that up to 81% of the 
sequenced gene could be mapped to culturable species (Griffen et al., 2012). The 
authors further confirmed findings from previous studies that certain species are 
more common in disease compared to health. In addition, the diversity of the 
community in diseased sites is significantly greater than in healthy sites (Griffen 
et al., 2012). However, a systematic review conducted by Pérez-Chaparro et al. 
(Pérez-Chaparro et al., 2014) suggested a rather different interpretation, in which 
the authors proposed that periodontal disease represents a community-wide 
perturbation of the entire microbial population of subgingival plaque with newly 
identified microorganisms being involved in the progression of periodontal 
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disease. The results of this systematic review support moderate evidence for the 
association of 17 newly identified species from the Bacteria domain, the 
Candidatus Saccharibacteria phylum, and the Archaea domain as aetiological 
agents of periodontal disease. Although the use of high through-put sequencing 
technology to study plaque microbiome has provided insights previously not 
possible due to methodological limitations, to date the “red” and “orange 
complexes” bacteria are still widely accepted as the prototype polymicrobial 
pathogenic consortium in periodontal disease evidenced by the vast research 
information on the pathogenicity of these microorganisms. 
 
1.3 Role of host immune response in the aetiology of periodontal disease 
Host innate immune system provides the first line of defence against microbial 
infection as it exerts a rapid and immediate response (Hoffmann et al., 1999). For 
instance, oral mucosa is bathed in saliva, which contains a number of 
antimicrobial factors such as lysozyme, peroxidase and lactoferrin (Tenovuo et 
al., 1990). Innate immunity also works through pattern recognition receptors 
(PRRs) predominantly expressed on cells of the innate immune system, including 
neutrophils, monocytes/macrophages, and dendritic cells that recognize pathogen-
associated molecular patterns (PAMPs) such as lipopolysaccharide (LPS) from 
gram-negative bacteria, peptidoglycan from gram-positive bacteria, and nucleic 
acids. Activation of PRRs subsequently induces genes responsible for the release 
of pro-inflammatory mediators to recruit more neutrophils, macrophages and 
lymphocytes to infiltrate tissues and thus amplify inflammation (Takeuchi and 
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Akira, 2010). Detection of these microbial structures allows for the maintenance 
and surveillance of microbial colonization, and therefore, oral commensal 
community strives to maintain homeostasis with the host immune system. 
 
Various PRRs are expressed in the periodontium including membrane-bound toll-
like receptors (TLRs) 1, 2, 3, 4, 5, 6 and 9 (Hans and Hans, 2011), cytosolic 
sensors nucleotide-binding oligomerization domains-1 and -2 (NOD-1 and NOD-
2) (Jeon et al., 2012; Uehara and Takada, 2007), and retinoic acid–inducible gene 
I (RIG-I) (Lee and Tan, 2014). Among these PRRs, the most studied are TLRs 
which function to maintain the periodontium in a healthy state. Gingival and 
periodontal fibroblasts are the two main cell types responsible for maintenance of 
tissue integrity and regenerative processes of periodontal tissues (Hou and 
Yaeger, 1993; Kuru et al., 1998). These cell types express TLRs 2, 4, and 9, 
which recognize peptidoglycan, LPS, and bacterial DNA, respectively (Jönsson et 
al., 2011b; Uehara and Takada, 2007). Activation of these PRRs triggers nuclear 
factor kappa-light-chain-enhancer of activated B-cells (NF-κB) activation, the 
prototypical pro-inflammatory signalling pathway, leading to the production of 
cytokines such as tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), 
interleukin-6 (IL-6), and interleukin-8 (IL-8). In a murine periodontal ligament 
cell line, mitogen-activated protein kinase (MAPK) pathways, such as 
extracellular-signal-regulated kinases (ERK) and c-jun N-terminal kinase (JNK) 
were demonstrated to be responsible for A. actinomycetemcomitans and 
Escherichia coli LPS induced IL-6 expression (Patil et al., 2006). These cytokines 
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play important roles in recruiting phagocytes to the site of infection to control 
bacterial infection. However, over activation of TLRs and the subsequent 
uncontrolled cytokines production contribute to chronic leukocyte recruitment and 
delay resolution of inflammation ultimately lead to host tissue destruction 
(Hajishengallis, 2009; Maheaswari et al., 2014). Indeed, high levels of these pro-
inflammatory cytokines are found in GCF of patients with periodontal disease 
(Lamster and Novak, 1992; Okada and Murakami, 1998). 
 
Neutrophils are professional phagocytes responsible for killing of pathogens. 
Increased number of neutrophils (Landzberg et al., 2015) accumulates at the 
periodontal lesions. Although neutrophils are essential to combat invading 
bacteria, aberrant neutrophil activity characterized by diminished or excessive 
recruitment, impaired function or hyperactivity result in disturbance of 
periodontal tissue homeostasis, leading to disease (Hajishengallis and 
Hajishengallis, 2014; Ryder, 2010). Neutrophils are destructive through releasing 
degradative enzymes, such as matrix metalloproteinases which are enzymes that 
degrade extracellular matrix proteins such as collagen, or cytotoxic substances, 
for example reactive oxygen species (ROS) that could damage lipid, DNA and 
proteins (Nussbaum and Shapira, 2011; Ryder, 2010). Neutrophils can also induce 
osteoclastogenesis through the expression of membrane-bound receptor activator 
nuclear factor kappa B ligand (RANKL) (Chakravarti et al., 2009). RANKL, its 
receptor RANK, and a decoy receptor osteoprotegerin (OPG) are key molecules 
in regulating osteoclast differentiation, recruitment, and function (Boyle et al., 
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2003). In bone pathology, RANKL interaction with RANK induces bone-
resorbing osteoclast differentiation. Indeed, RANKL protein expression was 
found to be elevated in the granulomatous tissue adjacent to areas of alveolar 
bone from periodontal disease patients (Crotti et al., 2003). Since neutrophils do 
not release soluble RANKL, they could mediate periodontal bone resorption only 
if they are in close proximity to the bone (Chakravarti et al., 2009). In a primate 
model of experimental periodontal disease, high numbers of infiltrated 
inflammatory cells and osteoclasts were observed in gingival connective tissue 
sections that are in close proximity to bone. This resorption can be ameliorated by 
inhibition of RANKL activity or by diminishing immune cell stimulation 
(Assuma et al., 1998). These observations implicate a link between inflammation 
and bone loss and suggest that neutrophil chemoattractant could be an important 
mediator for bone loss in the pathogenesis of periodontal disease (Tonetti et al., 
1998). 
 
1.4 Oral malodour or halitosis   
Patients with periodontal disease often suffer from oral malodour or halitosis 
(Morita and Wang, 2001c). Oral malodour or halitosis is an unpleasant breath 
emanating from the mouth that is predominantly caused by the production of 
volatile sulphur compounds (VSCs) from hydrolysis of peptides and proteins in 
the periodontal pockets (Porter and Scully, 2006). These VSCs include hydrogen 
sulphide (H2S), methyl mercaptan (CH3SH), dimethyl sulphide and dimethyl 
disulphide (Tonzetich, 1977). H2S and CH3SH are the two major oral malodour 
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components associated with periodontal disease and consist of approximately 
90% of the total VSCs of mouth air (Tonzetich, 1977).  
 
Clinically, VSC levels in mouth air increased with the increase of the number and 
depth of periodontal pockets (>3 mm) (Tonzetich, 1978; Yaegaki and Sanada, 
1992a; Yaegaki and Sanada, 1992b). The association between VSCs levels and 
degree of periodontal destruction was determined semi-quantitatively via insertion 
of filter paper soaked with lead acetate in the gingival crevice (Rizzo, 1966). The 
filter paper turned black or brown as a result of lead sulphide precipitation when 
on contact with H2S. A positive correlation was found between the amounts of 
H2S in the gingival crevice and the depth of the corresponding periodontal 
pockets. Soils-Gaffer et al. (Solis-Gaffar et al., 1980) reported H2S levels strongly 
correlated with the volume of GCF. Correspondingly, elevated VSCs levels were 
also observed in deep and inflamed pockets with bleeding on probing (Coli and 
Tonzetich, 1991) and with an increase in radiographic bone loss (Morita and 
Wang, 2001a; b). Of note, Persson reported H2S to be present at levels of up to 2 
mM in the GCF of patients with periodontal disease detected via a sensitive gas 
chromatograph fitted with a flame photometric detector (Persson, 1992). 
 
In 1990, Persson et al. examined the production of VSCs by 82 oral bacterial 
species isolated from subgingival plaque. The authors observed bacterial species 
that produced abundant levels of H2S in the presence of human heat-inactivated 
serum included T. denticola, T. forsythia and P. gingivalis (Persson et al., 1990). 
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Similarly, the same group reported a total of 12 subspecies of F. nucleatum were 
also found to produce high amounts of H2S from L-cysteine (Claesson et al., 
1990). In a separate study, subgingival plaque samples were isolated from 20 
chronic periodontal disease subjects and were individually analysed for 40 
bacterial species using checkerboard DNA–DNA hybridization approach. The 
corresponding sulphide levels from these sites were also determined using 
Diamond Probe/Perio 2000 system, a periodontal probe that is used to detect the 
presence of sulphide in periodontal pockets. The counts of “orange” and “red 
complex” species namely, F. nucleatum, P. gingivalis, T. denticola and T. 
forsythia were found to be significantly higher at sulphide positive sites 
(Torresyap et al., 2003). 
 
1.5 H2S as a biological gasotransmitter 
H2S is a colourless, flammable, water soluble gas which smells like rotten eggs. In 
the early days, H2S was perceived as a toxic gas or an environmental hazard 
emanating from sewers, swamps and effluents from industrial processes (Lloyd, 
2006). The effects of H2S intoxication include inhibition of central nervous 
system and impairment of respiratory system via inhibition of mitochondrial 
electron transport cytochrome c oxidase, an enzyme that catalyses oxidative 
phosphorylation, resulting in the disruption of the respiratory chain in a similar 
manner to hydrogen cyanide (Cooper and Brown, 2008; Reiffenstein et al., 1992). 
Individuals that are acutely exposed to high concentrations of H2S (>500 ppm) 
often fall unconscious and followed by apparent recovery, colloquially referred to 
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as “knockdown”. After recovery, many individuals report permanent neurological 
side effects including hallucinations, anosmia, headaches, poor concentration 
ability, impaired short-term memory, and impaired motor function (Kfir et al., 
2015). These observations suggest that H2S may have physiological functions in 
the brain. 
 
Abe and Kimura in 1996 proposed that H2S is endogenously generated in the 
brain via cystathionine-β-synthase (CBS) with amount ranging from 50-160 µM 
determined by colorimetric methylene blue assay. H2S selectively activates N-
methyl-D-aspartate receptor, an ion channel protein that allows positively charged 
ions to flow through cell membrane during synaptic transmission and therefore 
facilitates the induction of hippocampal long-term potentiation, a synaptic model 
of memory formation. These observations allowed the authors to propose 
endogenous H2S to be a neuromodulator in brain (Abe and Kimura, 1996). 
Shortly after, research on H2S grew drastically with several groups demonstrating 
this biologically active gas to be a potent vasorelaxant, decreasing blood pressure 
in rats (Hosoki et al., 1997; Zhao and Wang, 2002). Hereafter, H2S, together with 
nitric oxide (NO) and carbon monoxide (CO), were categorized into a family of 
labile biological mediators termed gasotransmitter, which share many similarities 
(Łowicka and Bełtowski, 2006; Wang, 2002). These properties include low 
molecular weight, short half-life and are lipophilic in nature allowing rapid 
diffusion through cell membranes without the aid of specific transporters 
(Wallace et al., 2015b). Furthermore, these gaseous mediators exert varied 
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biological effects on various targets in mammalian systems, resulting in responses 
that range from cytotoxic effects to cytoprotective actions. 
 
In mammalian systems, physiologically relevant concentrations of H2S have been 
reported to be in the range of nM to μM (Li et al., 2011). So far, strong evidence 
shows H2S regulates a wide range of physiological functions in mammalian 
systems including cardiovascular (Wallace and Wang, 2015), neuronal (Paul and 
Snyder, 2015), gastrointestinal (Wallace et al., 2015a), respiratory (Olson, 2015), 
renal (Koning et al., 2015), liver (Song et al., 2015), and reproductive systems (Li 
et al., 2015). In the cardiovascular system, endogenous H2S was shown to relax 
vascular smooth muscles and inhibit the proliferation of cultured vascular smooth 
muscle cells. These protective effects of H2S could aid in alleviating pulmonary 
arterial pressure and lessen the narrowing of the pulmonary arteries during acute 
or chronic exposure to hypoxia (Chunyu et al., 2003). In addition, H2S markedly 
reduced tissue injury associated with hypoxia by preserving mitochondrial 
function as it can ‘drive’ mitochondrial respiration through replacing oxygen as 
the terminal electron acceptor to generate adenosine triphosphate (ATP), 
particularly in circumstances where oxygen levels are very low, such as during 
ischaemia (Elrod et al., 2007). Zhao et al. (Zhao et al., 2003) showed 
pharmacological inhibition of endogenous H2S biosynthesis machinery in rats 
elevated blood pressure, further supporting H2S’s involvement in blood pressure 
regulation. Similarly, spontaneously hypertensive rats (SHRs) exhibit age-
dependent development of hypertension that correlates with diminished H2S 
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production in aortic tissues, while treatment of SHRs with NaHS suppressed the 
development of hypertension, decreased vascular damage and prevented 
thickening of vascular wall (Sun et al., 2015). These observed vasorelaxant effects 
of H2S were mediated via stimulation of the opening of vascular smooth muscle 
ATP-sensitive potassium (KATP) ion channels. This KATP ion channel was the 
first-identified molecular target of endogenous H2S. While in the brain, despite 
being a neuromodulator, H2S can also regulate the release of corticotropin-
releasing hormone (a peptide hormone involved in the stress response) from 
hypothalamus (Russo, 2000). Increased corticotropin-releasing hormone 
production was associated with Alzheimer’s disease. In fact, the levels of H2S in 
the brain of individuals with Alzheimer’s disease are lower than in age-matched 
healthy volunteers (Eto et al., 2002). In a rat model of ischaemic vascular 
dementia, plasma H2S levels were lower and correlated with the decreased 
number of neurons in the hippocampus. NaHS treatment significantly attenuated 
neuronal injury produced by ischaemic hypoxia via inhibiting apoptosis and 
improved neural functional performance (Zhang et al., 2009). Besides, in a mouse 
model of Parkinson disease, H2S levels in the substantia nigra and striatum (a 
brain structure that plays an important role in movement-related functions) were 
significantly lower than in healthy mice. H2S impeded Parkinson-disease like 
abnormalities, including movement dysfunction and microglial activation (Kida et 
al., 2011). In gastrointestinal systems, H2S was shown to increase vascular 
endothelial cell proliferation and migration, micro-vessel formation and the 
healing of wounds and ulcers both in vivo and in vitro. This was evidenced in rats 
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whereby the administration of H2S donors or L-cysteine (precursor for H2S 
synthesis) resulted in acceleration of the healing of ulcers in the stomach, while 
suppression of H2S synthesis via inhibitor of cystathionine-γ-lyase (CSE) led to a 
delay in wound healing (Wallace et al., 2007). Furthermore, H2S was 
demonstrated to protect pancreatic islets (contain beta cells that produce insulin) 
from apoptotic cell death induced by high glucose through alleviating oxidative 
stress (Okamoto et al., 2015). 
 
In the context of inflammation, experimental data showed that H2S can exert 
either pro- or anti-inflammatory effects depending on the cell types and 
concentrations of H2S used (Hegde and Bhatia, 2011; Zanardo et al., 2006). One 
of the key studies by Zanardo et al. (Zanardo et al., 2006) reported H2S to be an 
important endogenous anti-inflammatory mediator through exerting inhibitory 
effects on leukocyte adherence to the vascular endothelium in a carrageenan-
induced paw oedema model. Using intravital microscopy to examine the 
mesenteric microcirculation in rats, they demonstrated that administration of 
NaHS markedly and potently suppressed leukocyte adherence to the vascular 
endothelium and prevented extravasation of leukocytes. They also observed that 
the inhibition of endogenous H2S synthesis resulted in rapid induction of 
leukocyte adhesion to the vascular endothelium. These inhibitory effects of H2S 
are a consequence of suppression of the expression of cell adhesion molecules on 
both the endothelium (for instance, intercellular adhesion molecule (ICAM)-1 and 
P-selectin) and on the leukocyte (lymphocyte function-associated antigen (LFA)-
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1). Consistent with the findings of Zanardo et al. (Zanardo et al., 2006), mice that 
are heterozygous for the gene CBS, one of the major enzymes for synthesis of 
H2S exhibited reduced leukocyte-rolling velocity, increased vascular 
permeability, and increased numbers of adherent leukocytes in mesenteric venules 
(Kamath et al., 2006). Also, H2S resolves inflammation through promoting 
neutrophil apoptosis as excessive accumulation of inflammatory cells could 
contribute significantly to the development of chronic inflammation (Mariggio et 
al., 1998). Many other key mediators of inflammation are also regulated to some 
extent by H2S. For instance, in a zymosan-induced air pouch inflammation 
model where NaHS was injected intraperitoneally, macrophages became hypo-
responsive to inflammatory stimuli such as bacterial endotoxin or TNF-α (Dufton 
et al., 2012). Numerous studies on anti-inflammatory properties of H2S were 
flushed with excitement for the potential development of H2S-based anti-
inflammatory therapeutics. In fact, promising data has been generated during 
preclinical and early clinical trials. Nevertheless, the exact signalling mechanisms 
that govern the effects of H2S on various inflammatory systems remain unclear to 
date. Much research effort has been placed on the anti-inflammatory roles of H2S 
whereby H2S has been shown to inhibit phosphodiesterase activity resulting in the 
increase levels of intracellular cyclic adenosine monophosphate (cAMP) and/or 
cyclic guanidine monophosphate (cGMP), both of which are intracellular 
secondary messengers involved in down-regulating inflammatory response (Bucci 
et al., 2010; Moore and Willoughby, 1995). In addition, the reducing property of 
H2S itself could also contribute to its anti-inflammatory action where direct 
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scavenging between H2S and reactive oxygen/nitrogen species such as 
hypochlorous acid (HOCl) (Whiteman et al., 2005), peroxynitrite (ONOO-) 
(Whiteman et al., 2004) and nitrosothiol (•NO) (Whiteman et al., 2006) generated 
during oxidative stress has been proposed. Particularly, the anti-inflammatory 
effects of H2S have been attributed to the inhibition of NF-κB activity, which is 
the main transcription factor mediating expression of pro-inflammatory genes 
(Baeverle and Henkel, 1994; Lawrence, 2009). H2S has been shown to modify the 
cysteine 38 residue in NF-қB p65, consequently inhibiting phosphorylation, 
subsequent nuclear translocation and DNA binding activity of this transcription 
factor, leading to reduced pro-inflammatory gene expression such as monocyte 
chemotactic protein 1 (MCP-1) (Du et al., 2014; Sen et al., 2012; Stuhlmeier et 
al., 2009). 
 
On the contrary, pro-inflammatory effects of H2S were observed in several animal 
models of inflammation. Increased plasma levels of H2S and increased expression 
of enzymes involved in H2S biosynthesis, namely CBS or CSE or 3-
mercaptopyruvate sulphurtransferase (3-MST) have been reported in several 
animal models of septic shock (Hui et al., 2003), myocarditis (Hua et al., 2009), 
rheumatoid arthritis (Whiteman et al., 2010a), and atherosclerosis (Wang et al., 
2003). In an experiment where NaHS was injected into the hind paw of mice, an 
inflammatory state with loss of tissue organization and oedema formation were 
observed histologically. Additionally, the amounts of prostaglandin E2 (PGE2), a 
key mediator of immunopathology in chronic infections, were also significantly 
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increased in exudates of injected hind paw (di Villa Bianca et al., 2010). In mice 
subjected to cecal ligation and puncture (CLP)-induced sepsis, NaHS enhanced 
the expression of cell adhesion molecules such as ICAM-1, P-selectin and E-
selectin, thus promoting neutrophil infiltration (Zhang et al., 2007). Similarly, in a 
murine model of caerulein-induced acute pancreatitis, H2S exerted pro-
inflammatory effects through substance P, a neuropeptide that can specifically 
stimulate the chemotaxis of neutrophils as well as enhance cytokine secretion 
from phagocytes, which contributes to lung inflammation and lung injury (Bhatia 
et al., 2008). However, translating these findings to humans has so far been 
inconclusive. For example, in humans, ongoing inflammatory diseases such as 
psoriasis is associated with low plasma H2S levels (KH Alshorafa et al., 2012). 
 
Bacteria are known to produce H2S as a by-product of metabolism with no 
particular physiological function for several decades (Kadota and Ishida, 1972). 
The enzymes responsible for H2S production have so far been characterized in 
only four bacterial species. Bacillus anthracis, Pseudomonas aeruginosa, and 
Staphylococcus aureus synthesize H2S through CBS or CSE activity while 
Escherichia coli uses 3-MST. More recently, a seminal report showed bacterial-
derived H2S to also play signalling roles (Luhachack and Nudler, 2014). In this 
report, inactivation of the H2S generating enzymes in the aforementioned 
pathogens increased antibiotic susceptibility to different classes of antibiotics 
such as gentamicin, ampicillin, and nalidixic acid that have been shown to exert 
their bactericidal effect via oxidative stress (Gusarov et al., 2009; Kohanski et al., 
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2007). In addition, when cells from these four pathogens were treated with 
ampicillin or hydrogen peroxide (H2O2), the mutants lacking H2S biosynthetic 
genes incurred more DNA damage, a hallmark of oxidative stress. In E. coli 
lacking 3-MST, both H2O2 scavenging activity and superoxide dismutase activity 
were significantly reduced compared to the wild type bacteria. Importantly, 
supplementing H2S-null mutants with NaHS restored wild type phenotype of 
resistance, suggesting a role for endogenous H2S as an essential antioxidant 
defence mechanism in these bacteria (Shatalin et al., 2011). 
 
1.6 Gap in knowledge-role of H2S in the pathogenesis of periodontal disease 
Periodontal health associated microflora is dominated by gram-positive 
streptococci species where organisms with anaerobic requirements such as F. 
nucleatum, P. gingivalis, T. denticola and T. forsythia are also present but in 
fewer numbers (Hinrichs et al., 1985). During plaque biofilm formation, the first 
bacteria to colonize the salivary pellicle on the tooth surface are streptococci and 
gram-positive rods such as A. naeslundii (Fig. 1.4). The predominant oral 
streptococci in plaque include Streptococcus mitis, S. oralis, S. sanguinis and S. 
gordonii. A key virulence attribute of oral streptococci is H2O2 which has been 
hypothesized to equip the bacteria with competitive advantage during 
colonization of oral surfaces. More recently, H2O2 is shown to induce extracellular 
DNA (eDNA) release by S. gordonii and S. sanguinis for biofilm development 
and stabilization. Furthermore, the eDNA can also serve as source of genetic 
material for horizontal gene transfer between oral streptococci (Kreth et al., 
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2009). However, given the bactericidal property of H2O2, for bacteria to co-
aggregate with oral streptococci in plaque biofilm, bacterial species should 
possess mechanisms to overcome the cytotoxic effects of H2O2 (Kreth et al., 
2009; Zhu and Kreth, 2012).  
 
During the initial stages of plaque biofilm formation, close contact between F. 
nucleatum with oral streptococci can be expected. F. nucleatum is an anaerobic 
gram-negative spindle-shaped or fusiform rod. Although an obligate anaerobe, F. 
nucleatum exhibited a high degree of aero-tolerance and even increased in 
number in aerobic conditions for up to 2 days (Gursoy et al., 2010). This 
protective effect exhibited by F. nucleatum may also benefit other late anaerobic 
colonizers, for example P. gingivalis, T. denticola and T. forsythia, in the oral 
biofilm (Bradshaw et al., 1996). Indeed, P. gingivalis cannot survive in the 
planktonic state unless co-aggregated to F. nucleatum (Bradshaw et al., 1998; 
Diaz et al., 2002). F. nucleatum has been shown to co-aggregate well with S. 
gordonii and S. sanguinis in a saliva-fed flow cell in vitro and in mice (He et al., 
2012; Periasamy et al., 2009; Periasamy and Kolenbrander, 2009). It has also 
been demonstrated that oral streptococci co-aggregate only with F. nucleatum and 
not oral anaerobes such as P. gingivalis and Prevotella nigrescens (Bradshaw et 
al., 1998; Diaz et al., 2002). F. nucleatum functions as an important bridging 
organism for co-aggregation with oral streptococci and integration of the late 
colonizers into plaque biofilm, which are disease associated anaerobes such as P. 






Figure 1.4. Plaque biofilm formation on tooth surface. Adapted from Rickard, A. 
H., Gilbert, P., High, N. J., Kolenbrander, P. E., & Handley, P. S. (2003). 
Bacterial co-aggregation: an integral process in the development of multi-species 
biofilms. Trends in Microbiology, 11(2), 94-100. Figure was obtained from 
Elsevier with permission (license number 3778051412522). 
 
In subgingival plaque of patients suffering from periodontal disease, the amount 
of oral streptococci reduces significantly, with an overgrowth of gram-negative 
anaerobes including F. nucleatum, P. gingivalis, T. denticola and T. forsythia 
(Allaker, 2010; Hillman et al., 1985; Takeshita et al., 2012). These periodontal 
disease associated anaerobes are known to produce H2S in abundance through 
metabolism of sulphur-containing amino acids found either in GCF or produced 
from the proteolytic breakdown of macromolecules. However, the potential 
effects of H2S on oral streptococci and periodontal disease associated anaerobes 
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are currently unknown. In addition, although the amounts of H2S producing 
anaerobes increase in subgingival plaque during the transition from health to 
disease, the potential effects of H2S on the inflammatory response of cells in the 
periodontium have not been well characterized.  
 
1.7 Objectives of the study 
The aims of this study were i) to determine if H2S influences the survival of 
periodontal disease associated anaerobes, in particular F. nucleatum, under 
oxidative stress induced in aerobic conditions, ii) to determine if H2S affects the 
survival and biofilm formation of non H2S-producing oral streptococci, iii) to 
examine the effects of H2S on the inflammatory response of human primary 
periodontal fibroblasts in the presence or absence of TLR activation, and (iv) to 

















Streptococci and gram-positive rods such as Actinomyces naeslundii are the first 
microorganisms to colonize the tooth surface. Within the first 4 hours of plaque 
formation, Streptococcus mitis, S. oralis, S. gordonii and S. sanguinis constitute 
60–90% of the total bacteria culturable from dental plaque (Nyvad and Kilian, 
1990). These primary colonizers play central roles in initiating dental biofilm 
formation by providing binding sites for subsequent colonizers during the 
formation of plaque (Rickard et al., 2003). This is achieved through bacterial 
surface adhesins and receptors which serve as “community integration factors” for 
co-aggregation with compatible bacterial species (Jakubovics et al., 2014). F. 
nucleatum, a gram-negative anaerobe is often found in “corncob” formations with 
streptococci in dental plaque (Kolenbrander et al., 2010). Fusobacterium 
nucleatum possesses the remarkable ability to co-aggregate tenaciously with a 
wide variety of microorganisms. Due to its promiscuous adherence ability, F. 
nucleatum is regarded as an important ‘bridge’ organism between the early and 
late colonizers such as Porphyromonas gingivalis, Treponema denticola and 
Tannerella forsythia, which require interactions with other species to persist in 
plaque biofilm. Notably, the late colonizers are the bacterial species associated 
with periodontal destruction, and in the absence of F. nucleatum the amount of 
the late colonizers in plaque reduce significantly (Bradshaw et al., 1998; Diaz et 




In periodontal health, a symbiotic relationship exists between the host and health 
associated oral flora. This health associated flora is dominated by oral 
streptococci which constitute 74.3% of total cultivable flora. In contrast, the 
amount of oral streptococci diminished to 22.3% and the flora is instead 
dominated by gram-negative strict anaerobes (Listgarten and Hellden, 1978; 
Slots, 1979). Oral streptococci confer colonization resistance to pathogenic 
microorganisms through production of bacteriocins, a proteinaceous antibiotic 
(Wescombe et al., 2009) and hydrogen peroxide (H2O2) (Kreth et al., 2009). 
These factors likely enhance their survival in the oral cavity, and eliminate 
competing bacterial species such as P. gingivalis (Van Hoogmoed et al., 2008) 
and caries-causing S. mutans (Kreth et al., 2008). Compared to periodontal 
associated bacteria such as F. nucleatum and P. gingivalis, S. gordonii and S. 
sanguinis do not elicit inflammatory response in gingival epithelial fibroblast 
(Hasegawa et al., 2007; Peyret-Lacombe et al., 2009). In addition, S. mitis, and S. 
sanguinis and their culture supernatants suppress interleukin-8 (IL-8) production 
in human gingival fibroblasts triggered by Aggregatibacter 
actinomycetemcomitans, a perio-pathogenic bacteria associated with localized 
aggressive periodontitis (Devine et al., 2015; Sliepen et al., 2009). Collectively, 
these properties allow oral streptococci to co-exist in symbiosis with the host in 
the oral environment. 
 
If plaque is allowed to accumulate, the host begins to mount an inflammatory 
response to control the increase in bacterial load. Gingivitis or gum inflammation 
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can be detected after a 10-21 day period when bacterial load in plaque persists 
beyond levels compatible with periodontal health (Löe et al., 1965). GCF flow 
increases which introduces components of the host defences such as 
polymorphonuclear leukocyte (PMN) into the gingival crevice. These 
inflammatory processes subsequently activate the release of proteases, elastases 
(Smith et al., 1995), collagenases (Golub et al., 1997) and metalloproteinases 
(Hernández et al., 2010) that mediate the destruction of the gingival epithelial and 
connective tissues of the periodontium. Consequently, the junctional epithelium 
which is located at a strategically important interface between the gingival sulcus, 
and the periodontal soft and mineralized connective tissues migrates towards the 
apex of the tooth. Progressively, the gingival sulcus deepens due to the loss of 
connective tissue attachment to the root of the tooth and results in formation of a 
periodontal pocket. The environment of a periodontal pocket is low in oxygen 
tension which favours the survival of obligate anaerobic bacterial species (Marsh, 
2003). In addition, GCF that bathes the gingival sulcus also contains an array of 
host molecules such as haemoglobin and transferrin that can be exploited as 
primary nutrient sources by the proteolytic bacteria in the biofilm. The altered 
local environment in the periodontal pocket consequently leads to microbial shift 
from predominantly gram-positive facultative anaerobes to gram-negative 
proteolytic anaerobes such as F. nucleatum, P. gingivalis, T. denticola and T. 




Patients with periodontal disease often suffer from oral malodour or halitosis 
caused by VSCs emanating from the oral cavity (Morita and Wang, 2001c). This 
is attributed to increased amounts of gram-negative anaerobes (Torresyap et al., 
2003) in the periodontal pockets which produce H2S, methyl mercaptan and 
dimethyl sulphide through the metabolism of human serum proteins and sulphur-
containing amino acids such as L-cysteine (Persson et al., 1990). H2S is the 
predominant VSC found in 90% of diseased periodontal pockets with 
concentrations of up to 2 mM (Horowitz and Folke, 1973; Persson, 1992). 
Traditionally, H2S is regarded as a microbial by-product of sulphur metabolism in 
oral anaerobes with few studies available concerning its potential functional roles 
on oral flora (Clarke, 1953).  
 
Among the oral anaerobes, F. nucleatum has been reported to exhibit a high 
degree of aero-tolerance (Farias et al., 2001). Since the oral cavity is largely an 
aerobic environment, F. nucleatum is likely to encounter oxygen especially in the 
early stages of dental plaque development, during passage of the bacteria through 
oral fluids or following mechanical disruption of dental plaque. Mechanisms to 
overcome oxidative stress are also important for the bacteria to survive oxidative 
stress-mediated killing of phagocytes during invasion of host tissues. The ability 
of F. nucleatum to tolerate oxygen has so far been attributed to oxidative stress 
induced up-regulation of nicotinamide adenine dinucleotide (NADH) oxidase 




So far, reports have shown H2S to elicit opposite effects in oxidative stress 
response. H2S has been demonstrated to protect Bacillus anthracis, Pseudomonas 
aeruginosa, Staphylococcus aureus and Escherichia coli from the bactericidal 
effects of antibiotics by mitigating oxidative stress through up-regulating the 
activity of key antioxidant defence enzymes, such as superoxide dismutase (SOD) 
and catalase to detoxify reactive oxygen species (ROS) (Shatalin et al., 2011). 
However, the potential roles of H2S in mitigating oxidative stress of F. nucleatum 
and other periodontal anaerobes have not been characterized. Conversely, a recent 
report showed H2S elicited microbicidal activity by inducing oxidative stress 
through the inhibition these antioxidant enzymes (Fu et al., 2014). These 
seemingly contradictory reports led us to hypothesize that H2S may serve dual 
roles, where it enhances the survival of oral anaerobes during oxidative stress on 
one hand, but also exerts antimicrobial effects on oral streptococci, contributing to 
the decrease in health associated microflora. Although periodontal disease 
associated anaerobes produce H2S abundantly, it is currently unknown if H2S 
elicits protective or detrimental effects on oral bacteria. Thus, the aims of this 
study were i) to determine the effects of H2S on the survival of F. nucleatum 
under oxidative stress induced in aerobic conditions, and ii) to investigate the 
potential effects of H2S on the survival and biofilm formation of oral streptococci. 
Results obtained from this study will help us to delineate the potential 
contributory roles of H2S in the complex environment of multi-species oral 




2.2 Materials and Methods 
2.2.1 Bacterial strains and culture conditions 
Fusobacterium nucleatum ATCC 25586, Porphyromonas gingivalis ATCC 
53978, Treponema denticola ATCC 35405, Tannerella forsythia ATCC 43037, 
Streptococcus mitis ATCC 49456, Streptococcus oralis ATCC 35037, 
Streptococcus gordonii ATCC 35105 and Streptococcus sanguinis ATCC 10556 
were purchased from the American Type Culture Collection (ATCC). F. 
nucleatum and P. gingivalis were maintained on tryptic soy agar (TSA) 
supplemented with 5% of sheep blood (Oxoid). T. denticola was maintained in 
modified new oral spirochete (NOS) medium (Appendix I) by diluting at a ratio 
of 1:5 with fresh media weekly. T. forsythia was maintained on Brain heart 
infusion (BHI) agar (Acumedia) supplemented with N-acetyl muramic acid 
(NAM) (10 µg/mL) (Sigma), 0.5% of yeast extract (Acumedia), hemin (5 µg/mL) 
(Sigma), 5% of foetal bovine serum (Hyclone), and vitamin K (1 µg/mL) (Sigma). 
F. nucleatum, P. gingivalis, T. denticola and T. forsythia were incubated at 37°C 
in a DG250 anaerobic workstation (Don Whitley Scientific) supplemented with 
80% N2, 10% H2 and 10% CO2. One day prior to experiment, an isolated colony 
of either F. nucleatum or P. gingivalis was inoculated into 3 mL of BHI 
(Acumedia) supplemented with 0.5% of yeast extract, hemin (5 µg/mL) and 
vitamin K (1 µg/mL). T. forsythia was cultured in 3 mL BHI supplemented with 
NAM (10 µg/mL), 0.5% of yeast extract, hemin (5 µg/mL), 5% of foetal bovine 
serum, and vitamin K (1 µg/mL) and incubated at 37°C anaerobically for 24 h. S. 
mitis, S. oralis, S. gordonii and S. sanguinis were maintained on BHI agar. One 
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day prior to experiment, an isolated colony of the oral streptococci was inoculated 
into 3 mL of BHI and incubated at 37°C in an incubator supplied with 5% CO2 for 
24 h. 
 
2.2.2 Quantification of H2S  
The amount of H2S produced by oral bacteria was quantified by Clines methylene 
blue assay (Cline, 1969) with minor modifications. The methylene blue method is 
the most commonly reported method used in the literature to measure H2S in 
biological samples. At physiological pH 7.4, approximately one-third of the H2S 
exists as the un-dissociated compound and the remainder dissociates to HS- and 
H+. Further dissociation of HS- to sulfide anion (S2-) occurs only at high pH and is 
insignificant at physiological conditions. However, since both H2S and HS
- 
always coexist in aqueous solution, it is not possible to separate their effects and 
to conclude which of them is involved in signalling processes (Beauchamp et al., 
1984). Thus, H2S is frequently used to reflect the sum of the species H2S, HS
– or 
S2– present at physiological pH (Whiteman M etal., 2004). F. nucleatum, P. 
gingivalis, T. denticola, T. forsythia, S. mitis, S. oralis, S. gordonii and S. 
sanguinis (1 x 108 colony forming unit, CFU) were inoculated into their 
respective growth media with and without 5 mM L-cysteine (Sigma) and 
incubated at 37°C for 24 h under their respective culture conditions as described 
above. Thereafter, 10 µL of the overnight bacterial cultures were transferred to a 
96-well plate (Nunc) with 72 µL of 1% zinc acetate (in 3% NaOH; Sigma), after 
which 18 µL of a solution of 17.1 mM N, N-dimethyl-p-phenylenediamine 
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sulphate salt (Sigma) and 37.0 mM iron(III) chloride (Sigma) in 6 M hydrochloric 
acid was added. The reaction mixtures were incubated at room temperature for 10 
min prior to measuring absorbance readings at OD670 nm using a microplate 
reader (Biotek). The amount of sulphide produced was determined by 
constructing a H2S standard curve using NaHS (Sigma). NaHS dissociates to 
sodium ion (Na+) and hydrosulphide anion (HS–) in solution, then HS– associates 
with hydrogen ion (H+) to produce H2S (Abe and Kimura, 1996). A 1 M stock 
concentration of NaHS was freshly prepared by dissolving the flakes in BHI. 
Seven 2-fold serial dilutions of NaHS were carried out with the top standard of 10 
mM NaHS in a 96-well plate using BHI as the diluent. The amount of H2S 
produced was then normalized to the respective bacterial culture density.  
 
2.2.3 Bacterial growth determination 
F. nucleatum, P. gingivalis, T. denticola and T. forsythia (1 x 108 CFU/mL) were 
inoculated into their respective growth media without (control) and with NaHS (2 
mM) or L-cysteine (5 mM) in a final volume of 2 mL and incubated for 4, 8, and 
24 h at 37°C aerobically in 14 mL polystyrene snap cap tubes (Becton Dickinson) 
without shaking. Bacterial culture density was determined using a Nanodrop 2000 
(Thermo Scientific). Viability of F. nucleatum under aerobic incubation was 
determined as follows. BHI was inoculated with 1 x 108 CFU/mL F. nucleatum in 
a final volume of 2 mL without (control) and with NaHS (2 mM) or L-cysteine (5 
mM) and incubated for 2, 4, 8, 16, 32 h at 37°C aerobically in 14 mL polystyrene 
snap cap tubes (Becton Dickinson) without shaking. Viability of bacteria was 
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determined by serial dilution and plating on TSA with 5% sheep blood (Oxoid). 
Agar plates were then incubated anaerobically as described above and the number 
of bacterial colonies was enumerated after 48-72 h of incubation. The minimum 
inhibitory concentrations (MIC) of NaHS for oral streptococci were determined 
using broth micro-dilution assay (Andrews, 2001). A 96-well microtiter plate 
containing 100 µL of serially diluted NaHS dissolved in BHI was inoculated with 
1 x 106 CFU/mL bacteria. Bacterial culture density after incubation for 24 h at 
37°C with 5% CO2 were determined by taking optical density measurements at 
600 nm using a microplate reader. S. gordonii and S. sanguinis (1 x 106 CFU/mL) 
in BHI were inoculated into a 96-well microtiter plate and were left untreated 
(control), treated with NaHS (2 mM) for 16 h, with or without GSH depletion 
with diethyl maleate (DEM) (Sigma), or co-treated with DEM + NAC after which 
culture density was determined. S. mitis and S. oralis (1 x 106 CFU/mL) in BHI 
were inoculated into a 96-well microtiter plate and were left untreated (control), 
or treated with 5 mM glutathione precursor, N-Acetyl-L-cysteine (NAC; Sigma), 
in the presence or absence of NaHS (2 mM) for 16 h after which culture density 
was determined. S. mitis and S. oralis (1 x 106 CFU/mL) in BHI were inoculated 
into a 96-well microtiter plate and were left untreated (control), or treated with 0.5 
mM iron chelator, deferoxamine (DFO; Sigma), in the presence or absence of 






2.2.4 Determination of reactive oxygen species (ROS) production 
ROS production was quantified using the ROS-Glo H2O2 Assay kit (Promega) 
according to the manufacturer’s recommendation. Materials used for the 
experiments that required anaerobic incubation were pre-reduced in the anaerobic 
workstation one day prior to use. F. nucleatum (1x107 CFU) was harvested by 
centrifugation at 16,000 x g for 5 min, washed with sterile phosphate-buffered 
saline (PBS) three times and resuspended in PBS and inoculated into a 96-well 
plate. The plate was incubated anaerobically (control anaerobic) or aerobically in 
the absence (control aerobic) or presence of NaHS with H2O2 substrate for 2 h. 
Subsequently, ROS-Glo detection solution was added to each well, following 
which the suspension mixtures were incubated further for 20 min at room 
temperature before the relative luminescence units were measured using GloMax 
96 microplate luminometer (Promega). The amount of ROS generated was 
determined by constructing a standard curve using H2O2.      
                                                                                                                      
2.2.5 Reduced nicotinamide adenine dinucleotide (NADH) and oxidized 
nicotinamide adenine dinucleotide (NAD+) assay 
F. nucleatum was harvested by centrifugation at 16,000 x g for 5 min at 4°C, 
washed with 1 mL of sterile PBS three times and resuspended in 1% Triton-X-
100 (Steinmoen et al., 2002) with 0.1 mm glass beads (Scientific Industries Inc.) 
and lysed through simultaneous action of agitation and vortexing for 15 min using 
a Disruptor Genie 2 (Scientific Industries Inc.) (Uhl et al., 2005). The efficiency 
of lysis was determined by culture and plating on BHI agar plates. Cell debris was 
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removed by centrifugation at 4°C. The concentrations of protein in the lysates 
were determined using the Bradford reagent (BioRad). Equal amounts of bacterial 
lysates were used for NADH and NAD+ measurements using the NAD/NADH-
Glo Assay kit (Promega) according to the manufacturer's instructions. 
 
2.2.6 Transwell assay 
F. nucleatum (1 x 107 CFU) was cultured in BHI supplemented with L-cysteine in 
the bottom chamber of a transwell plate with 0.4 µm pore polycarbonate 
membrane inserts (Corning). An inoculum size of 1 x 107 CFU each of S. mitis, S. 
oralis, S. gordonii and S. sanguinis were cultured in the upper chambers of the 
transwell plate systems in BHI with or without 50 mg/mL methaemoglobin, a H2S 
scavenger (Sigma) for 16 h. The setup was incubated at 37°C aerobically with 5% 
CO2. Viability of the oral streptococci was determined by serial dilution and 
plating on BHI agar and incubated at 37°C with 5% CO2. The number of bacterial 
colonies was enumerated after 24 h of incubation. 
 
2.2.7 Biofilm formation 
Whole saliva was obtained from a volunteer in one sitting by expectoration into a 
polypropylene tube. Saliva was filter sterilized by passing it through a 0.2 μm 
syringe filter (Sartorius) and stored in single use aliquots at -70°C. A 96-well flat-
bottom microtiter plate was coated with whole saliva for 24 h. Overnight cultures 
of oral streptococci (1 x 106 CFU/mL) were inoculated into the saliva-coated plate 
in BHI in the presence or absence of NaHS. After 24 h, planktonic cells were 
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carefully transferred to another microtiter plate for subsequent serial dilution and 
plating on BHI agar plates to quantify planktonic titre. Biofilm formation was 
determined by crystal violet assay. The biofilm was washed once with sterile PBS 
to remove residual planktonic cells. The biofilm was fixed with methanol (Sigma) 
for 10 min, stained with 1% crystal violet (Sigma) for 30 min, and washed 5 times 
with distilled H2O to remove unbound crystal violet. Bound crystal violet was 
dissolved using 33% acetic acid (Sigma). The extracted crystal violet in 33% 
acetic acid was further diluted 1:2 with distilled H2O, and its absorbance read at 
OD580 nm by a microplate reader. Viability of bacteria in biofilm was 
determined by serial dilution and plating on BHI agar and incubated at 37°C with 
5% CO2. To elute biofilm cells from wells, 100 μL of BHI was added to the well 
and vigorous pipetting of the suspension was sufficient to remove the biofilm 
from the wells. The bacterial suspension was collected and vortexed to disperse 
the biofilm to a homogenous suspension prior to serial dilution and plating. 
 
2.2.8 Determination of intracellular sulphide 
An inoculum size of 1 x 108 CFU of either S. mitis, S. oralis, S. gordonii or S. 
sanguinis were inoculated into 1 mL BHI in 1.5 mL micro centrifuge tubes. The 
cultures were left untreated (control) or treated with 2 mM NaHS for 2 h. Cells 
were pelleted and the resulting cell pellets were washed twice with PBS. Cell 
pellet was resuspended in 1% Triton X-100 (Steinmoen et al., 2002) with 0.1 mm 
glass beads (Scientific Industries Inc.) and lysed through simultaneous action of 
agitation and vortexing for 15 min using a Disruptor Genie 2 (Scientific Industries 
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Inc.) (Uhl et al., 2005). Efficiency of lysis was determined by plating on BHI agar 
plates. Cell debris was removed by centrifugation (16,000 x g) for 10 min at 4°C. 
The intracellular sulphide concentrations were determined using the Clines 
methylene blue colorimetric assay described under section 2.2.2.  
 
2.2.9 Reduced glutathione (GSH) and oxidized glutathione (GSSG) assay 
Overnight bacterial cultures (1 x 108 CFU) were harvested by centrifugation 
(16,000 x g) at room temperature for 10 min. The resulting cell pellets were 
washed twice with PBS prior to lysis with 1% Triton-X 100 (Sigma) as described 
above. Cell debris was removed by centrifugation (16,000 x g) for 10 min at 4°C. 
The concentrations of protein in the lysates were determined using the Bradford 
reagent (BioRad). The intracellular GSH and GSSG concentrations were 
determined from equal amounts of bacterial lysates using the GSH/GSSG-Glo 
assay kit (Promega). S. gordonii and S. sanguinis (1 x 106 CFU/mL) were treated 
with 5 mM DEM treatment for 16 h to deplete intracellular GSH. DEM-treated S. 
gordonii and S. sanguinis were also co-treated with 5 mM N-Acetyl-L-cysteine 
(NAC) for 16 h to replenish intracellular glutathione. 
 
2.2.10 Statistical analysis 
All experiments were carried out on three independent occasions and each time in 
triplicate. Results were presented as mean ± standard deviation. Statistical 
significance was determined by one-way ANOVA with Tukey post-hoc analysis 
41 
 
using IBM SPSS Statistics 20 unless stated otherwise. Differences between 





2.3.1 H2S production by oral bacteria  
F. nucleatum, P. gingivalis, T. denticola, T. forsythia, S. mitis, S. oralis, S. 
gordonii and S. sanguinis did not produce detectable amounts of H2S in the 
absence of L-cysteine (Fig. 2.1 and 2.2). However in the presence of L-cysteine, 
the anaerobes namely F. nucleatum, P. gingivalis, T. denticola, and T. forsythia 
produced between 0.4-3 mM H2S with F. nucleatum producing the highest 
amount of H2S (Fig. 2.1 and 2.2). Notably, the oral streptococci examined did not 
produce detectable amounts of H2S. 
 
 
Figure 2.1. H2S standard curve. H2S was quantified by the Clines methylene blue 
colorimetric assay. H2S standard curve was constructed by performing 2-fold 
serial dilutions of the H2S donor (NaHS) with the top standard of 10 mM NaHS in 
a 96-well plate using BHI, NOS or NAM media as the diluents did not vary 
significantly (data not shown). The limit of detection of the assay was 1 µM H2S. 
A standard curve was run concurrently for every sample analyzed. The standard 


























Figure 2.2. Amount of H2S produced by oral bacteria. Oral bacteria were cultured 
in their respective growth media with and without L-cysteine (5 mM). F. 
nucleatum, P. gingivalis, T. denticola and T. forsythia were incubated at 37°C for 
24 h anaerobically. S. mitis, S. oralis, S. gordonii and S. sanguinis were incubated 
at 37°C for 24 h in an incubator supplied with 5% CO2. The amount of H2S 
produced was normalized to the culture density. Growth media ± L-cysteine 































2.3.2 H2S protected F. nucleatum from oxidative stress 
When exposed to aerobic conditions for 2 h, F. nucleatum produced 150 µM of 
H2O2 (Fig. 2.3-2.4). However, in the presence of NaHS, the amount of H2O2 
produced by F. nucleatum in response to oxidative stress was significantly 
reduced. To determine if H2O2 induced oxidative stress in F. nucleatum, changes 
in cytosolic reduced nicotinamide adenine dinucleotide (NADH) and oxidized 
nicotinamide adenine dinucleotide (NAD+) were determined. NADH is a key 
cofactor used by oxidoreductive enzymes for metabolic processes and a decrease 
in NADH/NAD+ ratio indicates cellular stress (Ying, 2008). Under anaerobic 
conditions, the ratio of NADH to NAD+ favoured the generation of NADH. 
However, this ratio decreased significantly when F. nucleatum was exposed to 
either H2O2 under anaerobiosis, or shifted from anaerobiosis to aerobic condition, 
















Figure 2.3. H2O2 standard curve. H2O2 was quantified by ROS-Glo H2O2 Assay 
kit. Two fold serial dilutions of H2O2 were carried out with the top standard of 10 
µM H2O2 in a 96-well plate using PBS. The limit of this assay was determined to 
be 0.5 µM H2O2. A standard curve was run concurrently for every sample 
analyzed. The standard curve shown was obtained from one occasion in triplicates 





















































Figure 2.4. Amount of H2O2 produced by F. nucleatum under aerobic and 
anaerobic incubation conditions. F. nucleatum was untreated (control anaerobic, 
control aerobic), or treated with NaHS (2 mM) and incubated at 37°C for 2 h. 
Total bacterial suspensions were collected and amounts of H2O2 were determined. 









































Figure 2.5. Effects of NaHS and L-cysteine on NADH/NAD+ ratios in F. 
nucleatum under oxidative stress. F. nucleatum (1 x 108 CFU/mL) were either 
untreated (control anaerobic) or treated with NaHS (2 mM), L-cysteine (5 mM), 
H2O2 (1 mM) individually or in combination with NaHS (2 mM), L-cysteine (5 
mM) and incubated anaerobically at 37°C for 2 h. F. nucleatum was also left 
untreated (control aerobic) or treated with either NaHS (2 mM) or L-cysteine (5 
mM) and incubated aerobically at 37°C for 2 h. Bacterial lysates were then 
harvested and NADH/NAD+ ratios were determined. *P < 0.05, ***P < 0.001 



























2.3.3 H2S supported the growth of F. nucleatum under aerobic conditions  
H2S relieved oxidative stress in F. nucleatum as indicated by an increase of 
NADH/NAD+ ratio (Fig. 2.5) and supported its growth under aerobic conditions 
(Fig. 2.6). In the absence of H2S, the growth of F. nucleatum could not be 
maintained for >4 h under aerobic conditions while supplementation with either 
NaHS or L-cysteine was sufficient to sustain their growth for >24 h (Fig. 2.6). 
The bacterial suspensions were further subjected to serial dilution and plating to 
enumerate the surviving bacterial colonies on agar plate. Under aerobic 
conditions, in the absence of H2S production, viability of F. nucleatum was 
maintained for up to 2 h, but decreased by 40% after 4 h and could not be 
maintained for >16 h (Fig. 2.7). In contrast, supplementation with either NaHS or 
















Figure 2.6. Effects of NaHS and L-cysteine on growth of F. nucleatum under 
aerobic incubation conditions. F. nucleatum (1 x 108 CFU/mL) in BHI were 
untreated (control), treated with NaHS (2mM) or L-cysteine (5 mM) for 24 h at 



























































Figure 2.7. Effects of NaHS and L-cysteine on viability of F. nucleatum under 
aerobic incubation conditions. L-cysteine, and NaHS were added into the BHI 
media inoculated with F. nucleatum (1 x 108 CFU/mL). The bacterial cultures 
were then incubated at 37°C under aerobic condition. At the indicated time points, 
amount of viable bacteria was determined by serial dilution and plating. **P < 







































2.3.4 H2S supported the growth of periodontal anaerobes under aerobic 
conditions  
Since H2S was able to protect F. nucleatum from oxidative stress elicited under 
aerobic conditions, the capability of H2S to protect the other periodontal 
anaerobes namely P. gingivalis, T. denticola and T. forsythia from oxidative stress 
was also examined. In the absence of H2S, the growth of P. gingivalis, T. 
denticola and T. forsythia could not be maintained for >4 h (Fig. 2.8A-C). 
Conversely, supplementation with either NaHS or L-cysteine was sufficient to 























































































Figure 2.8. Effects of NaHS and L-cysteine on growth of periodontal anaerobes 
under aerobic incubation conditions. (A) P. gingivalis, (B) T. denticola and (C) T. 
forsythia (1x108 CFU/mL) in their respective growth media were left untreated 
(control), treated with NaHS (2mM) or L-cysteine (5 mM) for 24 h at 37°C under 































(C) T. forsythia 
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2.3.5 Differential susceptibility of oral streptococci to H2S 
To determine the potential effects of H2S on oral streptococci, four species that 
did not produce H2S, namely S. mitis, S. oralis, S. gordonii and S. sanguinis (Fig. 
2.2) were treated with 2-fold serial dilution of NaHS, a H2S donor. The minimum 
concentration (MIC) of H2S required to inhibit the growth of S. mitis and S. oralis 
was 0.25 mM. However, the growth of S. gordonii and S. sanguinis were not 
affected at concentrations of up to 2 mM H2S, which is the highest concentration 
so far reported in the plaque of patients with periodontal disease (Persson, 1992). 
To determine if S. mitis and S. oralis are susceptible to H2S derived from F. 
nucleatum when in co-culture, a transwell setup was employed where F. 
nucleatum and the respective oral streptococci were placed in the lower and upper 
chambers respectively (Fig. 2.9). Presence of F. nucleatum led to approximately 
103- and 104-fold decrease in S. mitis and S. oralis viable counts respectively, 
while the presence of H2S scavenger rescued the viability of S. mitis and S. oralis 
in the presence of F. nucleatum (Fig. 2.10A and B). In contrast, viability of S. 
gordonii and S. sanguinis did not change significantly in the presence of F. 












Figure 2.9. Diagrammatic representation of the transwell setup used to investigate 
the bacteriostatic properties of H2S-producing F. nucleatum against S. mitis, S 











Figure 2.10. Effect of F. nucleatum-derived H2S on growth of S. mitis and S. 
oralis. (A) S. mitis (1 x 107 CFU) cultured in BHI (control) or (B) S. oralis (1 x 
107 CFU) cultured in BHI (control) was placed in the upper chamber of the 
transwell apparatus in the presence or absence of methaemoglobin (H2S 
scavenger), while H2S-producing F. nucleatum (1 x 10
7 CFU) was applied to the 
lower chamber. This setup was incubated aerobically at 37°C in 5 % CO2 for 16 
h. Viability of S. mitis and S. oralis were determined by serial dilution and plating 




































































Figure 2.11. Effect of F. nucleatum-derived H2S on growth of S. gordonii and S. 
sanguinis. (A) S. gordonii (1 x 107 CFU) cultured in BHI (control) or (B) S. 
sanguinis (1 x 107 CFU) cultured in BHI (control) was placed in the upper 
chamber of the transwell apparatus while H2S-producing F. nucleatum (1 x 10
7 
CFU) was added to the lower chamber. This setup was incubated at 37°C in 5 % 
CO2 incubator for 16 h. Viability of S. gordonii and S. sanguinis were determined 


























































2.3.6 H2S inhibited formation of streptococci biofilm 
The MIC of H2S for planktonic S. mitis and S. oralis was determined to be 0.25 
mM. At the MIC in the biofilm setup, significant amounts of S. mitis and S. oralis 
remained viable, albeit significantly reduced compared to the bacteria unexposed 
to H2S (Fig. 2.12A and B). These surviving bacteria adhered to saliva-coated 
surface to form biofilm as determined by crystal violet assay (Fig. 2.13A and B). 
Since crystal violet assay cannot differentiate between the extracellular polymeric 
substances (EPS) and bacterial cells (Welch et al., 2012), viability of bacteria in 
biofilm was additionally investigated by plating. Viable counts of S. mitis and S. 
oralis in biofilms were significantly affected in the presence of H2S (Fig. 2.14A 


















Figure 2.12. Effect of NaHS on planktonic cell growth of S. mitis and S. oralis. S. 
mitis and S. oralis were grown in saliva-coated polystyrene well plate in the 
presence and absence of NaHS from a starting inoculum of 1x106 CFU/mL for 24 
h. Unattached planktonic cells were then subjected to serial dilution and plating 
on BHI agar plates to quantify planktonic titre. Planktonic cell viability of (A) S. 
mitis (B) S. oralis in the presence and absence of NaHS from a starting inoculum 
of 1x106 CFU/mL after 24 h. ***P < 0.001 compared to amount of bacteria in the 











































































Figure 2.13. Effect of NaHS on biofilm formation of S. mitis and S. oralis. S. 
mitis and S. oralis biofilms were formed on saliva-coated polystyrene well plate 
in the presence and absence of NaHS from a starting inoculum of 1x106 CFU/mL 
for 24 h. The thickness of (A) S. mitis and (B) S. oralis biofilms were determined 
by crystal violet assay. ***P < 0.001 compared to amount of biofilms in the 
















































Figure 2.14. Effect of NaHS on biofilm formation of S. mitis and S. oralis. S. 
mitis and S. oralis biofilms were formed on saliva-coated polystyrene well plate 
in the presence and absence of NaHS from a starting inoculum of 1x106 CFU/mL 
for 24 h. Viability of (A) S. mitis and (B) S. oralis bacteria in biofilm was 
determined by serial dilution and plating on BHI agar plate. ***P < 0.001 




































































2.3.7 Susceptibility of oral streptococci to H2S is dependent on intracellular 
glutathione  
Intracellular sulphide levels were not detectable in S. mitis, S. oralis, S. gordonii 
and S. sanguinis (data not shown). Following treatment with NaHS, intracellular 
sulphide concentrations increased by up to 100 and 70 µM in S. mitis and S. oralis 
respectively (Fig. 2.15A). In contrast, sulphide did not accumulate to significant 
amounts in S. gordonii and S. sanguinis (Fig. 2.15A). Reduced glutathione (GSH) 
was found to be present in S. mitis, S. oralis, S. gordonii and S. sanguinis at 
concentrations ranging between 0.6-5 µM (Fig. 2.15B). Notably, S. gordonii and 
S. sanguinis possessed significantly higher concentrations of GSH compared to S. 
mitis and S. oralis (Fig. 2.15B). This contrasting inverse relationship between 
intracellular sulphide and GSH concentrations in oral streptococci led us to 
hypothesize that GSH may be able to directly detoxify H2S. NaHS was added to 
GSH under aerobic conditions in vitro and the amount of sulphide was quantified. 
GSH at 5 µM significantly reduced sulphide levels from NaHS (Fig. 2.16). To 
determine if GSH indeed protected oral streptococci against the bacteriostatic 
effects of H2S, intracellular GSH in S. gordonii and S. sanguinis was depleted 
with diethyl maleate (DEM), a glutathione-depleting agent, at a concentration that 
did not affect bacterial viability (Chasseaud, 1979). Depletion of intracellular 
GSH in S. gordonii and S. sanguinis led to accumulation of intracellular sulphide 
(Fig. 2.17A and B) and corresponding inhibition of bacterial growth (Fig. 2.18A 
and B). Conversely, when intracellular GSH was restored with N-acetylcysteine 
(NAC), a glutathione precursor, intracellular sulphide failed to accumulate to 
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significant amounts (Fig. 2.17A and B), allowing S. gordonii and S. sanguinis to 
grow despite H2S treatment (Fig. 2.18A and B). Exposure of S. mitis and S. oralis 
to H2S led to a decrease in GSH/GSSG ratio, an indicator of oxidative stress, 
which was mitigated in the presence of NAC (Fig. 2.19A). Correspondingly, the 





Figure 2.15. Effect of NaHS on intracellular sulphide levels of oral streptococci 
and quantification of the amount of intracellular GSH in oral streptococci. (A) 
Intracellular sulphide concentrations in S. mitis, S. oralis, S. gordonii and S. 
sanguinis following treatment with NaHS (2 mM) for 2 h. (B) Cellular GSH 
levels of S. mitis, S. oralis, S. gordonii and S. sanguinis were determined by 




































































Figure 2.16. Effect of GSH on sulphide level in vitro. NaHS (2 mM) was added 
to GSH at the indicated concentrations and the remaining sulphide levels were 





































Figure 2.17. Effect of NaHS on intracellular sulphide levels of GSH-deficient S. 
gordonii and S. sanguinis. (A) S. gordonii or S. sanguinis in BHI (control) or 
treated with either DEM or DEM + NAC for 16 h prior to determination of 
intracellular GSH concentrations. (B) S. gordonii and S. sanguinis were left 
untreated (control) or treated with NaHS (2 mM) for 2 h after overnight treatment 
with DEM (5 mM), or co-treatment with DEM + NAC prior to determination of 







































































Figure 2.18. Effect of NaHS on growth of GSH-deficient S. gordonii and S. 
sanguinis. Culture density of (A) S. gordonii and (B) S. sanguinis in BHI without 
treatment (control), treated with NaHS (2 mM) for 16 h, with or without GSH 

























































































































Figure 2.19. Effect of NaHS on GSH/GSSG ratios and growth of S. mitis and S. 
oralis. (A) GSH/GSSG ratio in S. mitis and S. oralis in BHI were left untreated 
(control), treated with NaHS (2 mM) for 2 h in the presence or absence of NAC. 
Culture density of (B) S. mitis and (C) S. oralis without treatment (control), or 
treated with NaHS (2 mM) in the presence of absence of NAC for 16 h in BHI. *P 






























2.3.8 Iron sequestration rescued oral streptococci from H2S 
H2S has been shown to reduce intracellular bound ferric iron to form unbound 
ferrous iron causing an increase in cytosolic iron (Truong et al., 2006). Free 
cytosolic iron can either act as a substrate for Fenton reaction to generate highly 
microbicidal free radicals, or directly inhibit bacterial enzymes in oral 
streptococci (Dunning et al., 1998). To determine if H2S exerts its bacteriostatic 
effects through an iron-mediated pathway, S. mitis and S. oralis were exposed to 
NaHS in the presence and absence of deferoxamine (DFO), a ferric chelator, at a 
concentration (0.5 mM) that did not affect bacterial viability on its own. In the 
presence of DFO, the bacteriostatic effect of H2S on S. mitis and S. oralis was 



















Figure 2.20. Effect of deferoxamine on growth of NaHS-treated S. mitis and S. 
oralis. (A) S. mitis and (B) S. oralis in BHI were left untreated (control), or 
treated with DFO (0.5 mM) in the presence or absence of NaHS (2 mM) for 16 h 

























































The anatomical niche of the periodontal pocket where oxygen tension is low 
provides a favourable environment for anaerobes such as F. nucleatum, P. 
gingivalis, T. denticola and T. forsythia to flourish. In periodontal disease, GCF 
flow increases 30 times compared to health (Goodson, 2003). The dissolved 
oxygen in GCF approximates that of serum levels, with values similar to those for 
venous blood with an average PO2 (partial pressure of oxygen) of about 30 mm Hg 
(Lamont et al., 2006). Furthermore, neutrophils and macrophages produce free 
radicals to kill invading plaque bacteria. Since oxygen and ROS diffuse readily 
through channels and pores in biofilms (Stoodley and Lewandowski, 1994), 
periodontal anaerobes must be equipped with mechanisms to overcome periods of 
oxidative stress (Lamont et al., 2006). Unlike aerobes or facultative anaerobes, 
periodontal disease associated anaerobes generally lack or express low levels of 
superoxide dismutase and catalase to detoxify ROS (Fig. 2.21) (Caldwell and 
Marquis, 1999; Henry et al., 2012; Kapatral et al., 2002). Accumulation of ROS 
intracellularly will kill these anaerobes through splitting of nucleic acids (Imlay 
and Linn, 1988), denaturation of proteins (Cabiscol et al., 2010) and damaging the 
integrity of cell membrane (Cabiscol et al., 2010). 
 
 
Figure 2.21. Catalytic activity of 
superoxide dismutase and catalase. 
Superoxide dismutase catalyses the 
destruction of the superoxide (O2
-) free 
radical. Catalase is an enzyme responsible 




H2S is produced in abundance by F. nucleatum, P. gingivalis, T. denticola and T. 
forsythia as the by-product of anaerobic metabolism (Persson et al., 1990). This 
occurs via the activity of  L-cysteine sulfhydrase (Chu et al., 1997; Fukamachi et 
al., 2002) using L-cysteine as the substrate. 
 
 
Figure 2.22. Anaerobic metabolism of L-cysteine to produce H2S. 
 
 
The sulphur in H2S is in the − 2 oxidation state which is the most reduced form of 
sulphur. This two-electron redox potential of H2S makes it a reductant and is 
regarded as the simplest thiol (Bianco and Fukuto, 2015) in nature. 
 
 




F. nucleatum lacks the major oxidative stress transcriptional regulators such as 
SoxR and H2O2-inducible genes activator (OxyR) and enzymes such as 
glutathione reductase, glutathione peroxidase and glutathione synthetase that are 
vital in maintaining a reducing condition intracellularly (Kapatral et al., 2002). 
Instead, the alkyl hydroperoxide reductase/ thioredoxin reductase (AhpC/TrxR) 
redox system has been shown to play a prominent role in the response of F. 
nucleatum to oxidative stress arising from H2O2 and oxygen (Steeves et al., 2011). 
In the presence of the small disulphide redox protein AhpC, NADH oxidase 
shows scavenging activity for H2O2. Hence, in F. nucleatum, AhpC-linked NADH 
oxidase system may function as the peroxide-scavenging system and to regenerate 
NAD+ in order to maintain oxidative and reductive balance in bacteria (Fig. 2.24) 
(Nishiyama et al., 2001).  
 
Figure 2.24. Oxidation of NADH. In the presence of the AhpC protein, the 
NADH oxidase could scavenge H2O2 to regenerate NAD
+ to maintain a balanced 
oxidoreductive environment in bacterial cytosol. NAD+ is reduced to form NADH 
+ H+ in the process of glycolysis. 
 
In this study, we showed that NADH/NAD+ ratios in F. nucleatum decreased 
significantly when treated with H2O2 or exposed to atmospheric oxygen. While 
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H2S supported the survival of F. nucleatum under aerobic conditions by restoring 
the NADH: NAD+ ratios. Indeed, H2S has been reported to directly scavenge ROS 
such as hypochlorous acid (HOCl) (Whiteman et al., 2005). Hence, their ability to 
produce H2S could serve as a means to reduce the overall oxygen tension in the 
local environment to enhance the survival of periodontal anaerobes during periods 
of oxidative stress.  
 
It is well established that periodontal disease development is the result of the loss 
of microbial haemostasis leading to a dysbiotic microbiota. Although H2S is 
beneficial to the survival of oral anaerobes, we showed that it exerted toxicity to 
certain oral streptococci species. Both exogenously added H2S as well as H2S 
derived from F. nucleatum inhibited the growth and biofilm formation of S. mitis 
and S. oralis, but not S. gordonii and S. sanguinis. This differential susceptibility 
of oral streptococci species to H2S toxicity was attributed to their differing 
intracellular GSH levels. GSH is the most abundant intracellular thiol present in 
eukaryotes. Its presence in prokaryotes has so far been described in cyanobacteria, 
proteobacteria and some gram-positive bacteria such as Streptococcus 
pneumoniae (Potter et al., 2012) and Lactobacillus lactis (Li et al., 2003). In 
prokaryotes, GSH has been demonstrated to confer protection against various 
physiological insults such as ROS, osmotic stress and toxic metal ions (Fahey, 
2013; Masip et al., 2006). Under these conditions, GSH plays a central role in the 
maintenance of normal cellular processes through its action as a protein reductant 
either directly or via enzyme-mediated action. For instance, GSH protected E. coli 
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from toxic chlorine compounds such as hypochlorous acid (HOCl) and 
monochloroamine directly through its action of scavenging chlorine oxidants 
(Chesney et al., 1996) while GSH detoxifies xenobiotics (Pegram et al., 1997), 
electrophiles and antibiotics (Perito et al., 1996) via GSH-S-transferase (GST) 
which catalyses conjugation reaction with GSH to produce less toxic and more 
hydrophilic products that can be partially metabolized and excreted (Fahey, 
2013). Here, we showed that GSH could directly detoxify H2S in vitro. 
Nevertheless, GSH-mediated resistance of S. gordonii and S. sanguinis to 
sulphide toxicity could also occur via enzymatic means since enzymes involved in 
cellular redox regulation such as GSH reductase (GR), GST, and GSH peroxidase 
(GPx) (Fig. 2.25) are encoded in the genome of S. gordonii and S. sanguinis 
(Vickerman et al., 2007; Xu et al., 2007). Under normal physiological conditions, 
the intracellular ratio of GSH: GSSG is tightly regulated and GSH is kept mostly 
in its reduced form. Cysteine thiol groups have key catalytic functions in enzymes 
but are readily oxidized by ROS. Free cysteine is especially sensitive to 
autoxidation because the free amino group of cysteine, and the carboxyl group, 
can enhance the ability of the thiolate residue to bind heavy metals. In contrast to 
cysteine, GSH is resistant to auto-oxidation. Under oxidative stress, ROS 
mediates formation of intramolecular or intermolecular disulphide bonds between 
cysteine residues resulting in aberrant protein functions. In this context, GSH 
maintains protein thiols in the reduced state by itself being preferentially oxidized 
to GSSG so that essential cellular proteins are not damaged by oxidation (Fahey, 
2013). In E. coli mutants deficient in GSH, enzymes involved in toxic sulphate 
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catabolism for instance, 3′-phosphoadenylylsulfate reductase and methionine 
synthase are inactivated in the presence of an oxidizing agent (Hondorp and 
Matthews, 2004; Lillig et al., 2003). In the case of S. mitis and S. oralis where 
intracellular GSH levels are insufficient to detoxify H2S, a significant decrease in 
GSH: GSSG ratio was observed. Restoring the GSH: GSSG redox with NAC, a 
precursor for GSH biosynthesis, protected these bacterial species against the 
deleterious effects of H2S.  
 
Figure 2.25. Glutathione redox cycle. The enzymes, GPx, GST, and GR use GSH 
as substrate, and their actions result in fluctuations in the GSH: GSSG ratio. 
Products from GPx and GST can be excreted from cells, requiring re-synthesis of 
GSH; whereas intracellular GSSG is re-cycled to GSH by GR and nicotinamide 
adenine dinucleotide phosphate (NADPH). 
 
H2S-mediated toxicity in S. mitis and S. oralis could be prevented with an iron 
chelator. One of the main mechanisms of H2S-mediated toxicity is attributed to its 
ability to elicit the release of iron from ferritin into the cytosol as unbound toxic 
iron (Truong et al., 2006). H2S is sensitive to trace metal-mediated auto-oxidation 
in aerobic solution could generate O2




proteins containing iron–sulphur (Fe–S) clusters, destabilize the cluster, and 
triggering the release of ferrous (II) (Fe2+) (Equation 4). This free cytosolic iron 
could subsequently generate highly reactive and extremely damaging hydroxyl 
radical (HO·) via the Fenton (Equation 5) or Haber–Weiss reactions (Equation 6) 
(Truong et al., 2006), leading to damage of cell membranes, proteins and nucleic 
acids.  
 
Figure 2.26. Molecular mechanisms of hydrogen sulphide toxicity. In solution, 
disproportion of H2S generates HS
- and H+ which are subsequently auto-oxidised 
to make O2
-. This radical could attack proteins containing Fe–S clusters, 
triggering the release of Fe2+. This cytosolic free iron serves as substrate for 
Fenton reaction and later Haber-Weiss reaction to produce highly reactive ROS 
such as hydroxyl radical. In addition, iron is also capable of inducing cell damage 
through radical-independent means. For instance, Fe2+ has been shown to be 
lethal to streptococci by inhibiting F-ATPase activity, consequently affecting the 
organism’s ability to carry out glycolysis (Dunning et al., 1998).  
 
In summary, this study showed that H2S protected the periodontal anaerobe F. 
nucleatum from oxidative stress during aerobic conditions. In addition, H2S 
exerted toxicity to certain oral streptococci species, potentially contributing to 
dysbiosis in plaque biofilm through reduction of periodontal health associated 
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microflora. Cellular GSH in oral streptococci was important to overcome toxicity 
of H2S. Thus, compounds which augment cellular GSH in oral streptococci 
maybe beneficial to enhance the survival of oral streptococci against H2S 













Differential effects of H2S on inflammatory response 






Patients with periodontal disease often present with oral malodour, which is 
attributed to volatile sulphur compounds (VSCs) produced by periodontal disease 
associated bacteria (Yaegaki and Sanada, 1992b; Yoshida et al., 2009). In 
addition to being a problem that impairs self-confidence and social interactions 
leading to low self-esteem, depression and other mood disorders (Zalewska et al., 
2012), there is sufficient scientific evidence now to implicate VSCs in the 
impairment of normal physiological functions of healthy oral tissues (Tonzetich, 
1996). VSCs were shown to increase the permeability of gingival epithelium 
by >75% (Ng and Tonzetich, 1984), thus allowing greater penetration of 
lipopolysaccharide (LPS) into gingival epithelium consequently inducing 
inflammation. Pioneering studies on VSCs focused on the effects of methyl 
mercaptan (CH3SH) on the functions of oral tissues (Yaegaki and Sanada, 1992b). 
This was largely attributed to the lack of data on the VSCs species that 
predominate in the gingival crevicular fluid (GCF) and subgingival plaque. 
CH3SH suppresses wound healing by decreasing motility and collagen synthesis 
of gingival and periodontal fibroblasts, and increases collagen degradation 
(Lancero et al., 1996). In addition, CH3SH induces pro-inflammatory effects by 
eliciting prostaglandin E2 (PGE2) and matrix metalloproteinase-1 (MMP-1) 
production in gingival fibroblasts, both of which are important mediators of 
inflammation and tissue destruction (Ratkay et al., 1995). The availability of 
sensitive gas chromatographic methods led to the delineation of the composition 
and abundance of VSC components in oral fluids and plaque (Persson, 1992). 
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Persson reported H2S to be the dominant oral malodour species in 90% of 
diseased periodontal pockets. This was followed by the invention of an H2S 
incubation system by Yaegaki et al. (Murata et al., 2008) to investigate the effects 
of H2S on the physiological functions of oral tissues. H2S at concentrations of 
between 5-100 ng/mL in culture media, which is lower than those encountered in 
GCF, was sufficient to induce apoptosis and genomic DNA damage of gingival 
fibroblasts (Murata et al., 2008), gingival epithelial cells (Takeuchi et al., 2008), 
keratinocyte stem cells and osteoblasts (Aoyama et al., 2012) following 48 hours 
exposure. Irie et al. reported that H2S potentiated LPS-mediated 
osteoclastogenesis in rat periodontal tissues leading to enhanced bone resorption. 
This effect was attributed to the synergistic effects of H2S and LPS which 
potentiated toll-like receptor (TLR) 4 expression (Irie et al., 2012).  
 
Although cells of the innate immune system such as dendritic cells (DCs), 
neutrophils or macrophages play critical roles in the control of invading plaque 
bacteria during the initiation of periodontal disease (Janeway et al., 2002), the 
primary source of chemokines is from the resident cells of the oral cavity. For 
instance, following activation of TLRs, gingival epithelial cells and fibroblasts 
produce interleukin-8 (IL-8) in abundance to attract and activate the migration of 
these immune cells to the sites of infection (Baggiolini et al., 1989; Silva et al., 
2007). In the periodontium, periodontal fibroblasts are the main resident cell type 
associated with the formation and maintenance of the mineralized supporting 
structures (Beertsen et al., 1997). More recently, this cell type has been found to 
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express surface receptor pattern recognition receptors (PRRs) such as TLRs 2, 4, 
9 and intracellular PRR such as Nod-like receptors (NLRs) 1 and 2 which are 
responsible for the recognition of conserved microbial structures such as 
peptidoglycan and LPS (Tang et al., 2011). Activation of these PRRs leads to the 
activation of intracellular signalling cascades eliciting cytokines and chemokines 
production in response to invading bacteria in plaque biofilm (Jönsson et al., 
2011a; Mahanonda and Pichyangkul, 2007; Sun et al., 2010; Tang et al., 2011). 
Additionally, periodontal fibroblasts have been demonstrated to stimulate the 
migration of DCs and macrophages through soluble factors released in a co-
culture transwell migration assay (Konermann et al., 2012). Collectively, these 
observations suggest that periodontal fibroblasts are not just passive bystander 
cells, but likely participate in mounting an immune response against invading 
bacteria in plaque biofilm.  
 
High amounts of H2S producing anaerobes namely F. nucleatum, P. gingivalis, T. 
denticola and T. forsythia reside in the subgingival plaque of periodontal pockets 
of diseased individuals. H2S has been reported to be abundant in subgingival 
plaque with concentrations of up to 2 mM (Persson, 1992). So far, the role of H2S 
in inflammation is controversial despite numerous studies being carried out, 
where this gaseous mediator has been shown to induce pro- and anti-
inflammatory effects. For instance, in human macrophages, H2S stimulated the 
production of tumour necrosis factor alpha (TNF-α), interleukin-1β (IL-1β) and 
interleukin-6 (IL-6) (Zhi et al., 2007) while H2S-derived from P. gingivalis 
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induced IL-8 production in gingival epithelial cells (Chen et al., 2010). Fibroblast-
like synoviocytes treated with NaHS, a widely used H2S donor, showed elevated 
expression of IL-6, IL-8 and PGE2 (Kloesch et al., 2012; Papapetropoulos et al., 
2015). In the gastrointestinal tract, H2S derived from enteric bacteria promoted 
constitutive synthesis of PGE2 (Serhan et al., 2007; Wallace and Devchand, 
2005). In vivo,  introduction of NaHS into the hind paw of mice led to oedema 
and increase in PGE2 (di Villa Bianca et al., 2010).  
 
On the contrary, H2S inhibited LPS-mediated production of TNF-α, IL-1β and IL-
6 in a dose-dependent manner in macrophages (Whiteman et al., 2010b). 
Furthermore, H2S elicited neutrophil apoptosis as a mean to resolve inflammation 
and also to promote differentiation of macrophages into the “M2” phenotype that 
can phagocytose apoptotic neutrophils, thus promoting clearance of infiltrated 
leukocytes (Mariggio et al., 1998). In vivo, H2S reduced inflammation in a variety 
of animal models of inflammation. For instance, H2S decreased inflammation of 
kaolin/ carrageenan-induced mono-arthritis in rats (Ekundi‐Valentim et al., 2010), 
tobacco smoke-induced lung inflammation in mice (Han et al., 2011), ischaemia-
reperfusion injury in mice (Elrod et al., 2007), and in rat (Wallace et al., 2009) 
and mouse (Hirata et al., 2011) models of colitis.  
 
Although periodontal fibroblasts are likely exposed to large amounts of H2S due 
to their close proximity to H2S producing anaerobes present in the subgingival 
plaque, to date there is only one recent study which reported that H2S potentiated 
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P. gingivalis LPS induced IL-6 and IL-8 expression in periodontal fibroblasts 
(Chi et al., 2014). However, this study did not address the conflicting pro- and 
anti-inflammatory properties of H2S reported in other cell models and in vivo. 
Thus, the aims of this study were i) to determine the effects of H2S on 
inflammatory response of periodontal fibroblasts in the presence and absence of 
TLR activation and ii) to delineate the intracellular signalling pathways mediating 
these responses in periodontal fibroblasts. Results obtained from this study will 
help us to understand the roles of H2S in modulating inflammatory responses of 




3.2 Materials and Methods 
3.2.1 Cell culture conditions 
Primary human periodontal fibroblasts were obtained from ScienCell. The cells 
were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 4 mM L-glutamine (Hyclone) and 10% heat-inactivated foetal 
bovine serum (FBS) (Hyclone). Cells were incubated in a humidified atmosphere 
with 5% CO2 at 37
°C. All experiments were performed using cells between 
passages 4 and 8 (Jönsson et al., 2011b; Morandini et al., 2013). 
 
3.2.2 Reagents 
Sodium hydrosulphide (NaHS) (Sigma) was dissolved in DMEM. Stock 
concentrations of signalling pathway inhibitors such as SB203580 (an inhibitor of 
p38 MAPK pathway) (20 mM), BAY 11-7082 (an inhibitor of NF-κB activation) 
(10 mM) (Cayman Biochem) and inhibitor of transcription namely actinomycin D 
(5 mg/mL) (ActD) (Sigma) were prepared in dimethyl sulphoxide (DMSO). The 
TLR2 agonist, Pam3CSK4 (PAM), and TLR4 agonist, ultra-pure LPS (LPS), were 
purchased from Invivogen. These agonists were dissolved in sterile endotoxin-
free water to make 1 mg/mL stock solutions.  
 
3.2.3 Cell viability assay  
The effects of H2S on viability of cells were determined by the CellTiter Aqueous 
One Solution Cell Proliferation Assay kit (Promega) according to the 
manufacturer’s protocol. Periodontal fibroblasts (1.25 x 104 cells/well) were 
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seeded in a 96-well flat-bottom microtiter plate (Nunc) in DMEM complete media 
and allowed to adhere overnight. The next day, the cells were subjected to NaHS 
treatment. Periodontal fibroblasts were treated with NaHS, at concentrations 
ranging from 0.25-2.0 mM for 24, 48 and 72 h. Dissolved NaHS was added fresh 
for every cycle of 24 h for both 48 h and 72 h treatment regimens. Absorbance at 
490 nm was measured using a microplate reader (BioTek).  
 
3.2.4 PCR expression array 
Periodontal fibroblasts were left untreated (control) or treated with 2 mM NaHS 
for 4 h and incubated at 37°C in a humidified atmosphere with 5% CO2. Total 
RNAs were isolated using RNeasy Mini Kit (Qiagen) according to the 
manufacturer’s protocol. On-column DNaseI treatment was carried out to remove 
residual DNA from the extracted RNA samples. The amount of RNA was 
quantified using a Nanodrop 2000 (Thermo Scientific). Approximately 500 ng of 
total RNA was used for reverse transcription (RT) using the RT2 First Strand Kit 
from SuperArray Bioscience according to the manufacturer’s protocol. 
Quantitative polymerase chain reactions (qPCR) were performed using the RT2 
ProfilerTM PCR Array from SuperArray Bioscience. The thermal cycling protocol 
used was an initial denaturation at 94°C for 3 min and denaturation at 94 °C for 
30 s, annealing at 56 °C for 30 s and extension at 72°C for 50 s. PCR was carried 
out for 40 cycles in a CFX Connect Real Time PCR System (BioRad). A total of 
84 genes were analysed for relevant human genes involved in innate immune 
responses (Table 3.2). Five genes including beta actin (ACTB), β2 microglobulin 
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(β2M), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hypoxanthine 
phosphoribosyltransferase (HGPRT) and ribosomal protein, large, P0 (RPLP0) 
served as the housekeeping controls and the average of their Ct values was used to 
normalize gene expression via the 2−∆∆Ct method (Schmittgen and Livak, 2008). 
Gene expression was considered up-regulated or down-regulated when the fold 
change was >2.  
 
3.2.5 Validation of H2S-induced genes expression 
The kinetics of up-regulated gene expression was assessed after 4, 8, and 24 h 
post NaHS treatment. Similarly, total RNA was extracted as described in section 
3.2.4 followed by RT reaction using iScriptTM cDNA synthesis kit (Bio-Rad). 
Briefly, RT reaction mixture was assembled on ice with 500 ng DNase I-treated 
RNA, 4 μL of 5x RT reaction mix and topped up to a total volume of 20 μL with 
nuclease-free water. An initial annealing step was carried out at 25°C for 5 min, 
followed by complementary DNA (cDNA) synthesis at 42°C for 30 min. 
Inactivation of the reverse transcriptase was performed by heating at 85°C for 5 
min. qPCR was carried out using iTaq Universal SuperMix (BioRad) in a CFX-96 
Connect Real-time PCR System. Sequences of the primers used are listed in Table 
3.1. The thermal cycling protocol used was an initial denaturation at 94°C for 3 
min and denaturation at 94 °C for 30 s, annealing at 56 °C for 30 s and extension 
at 72°C for 50 s. PCR was carried out for 40 cycles. Expression of the targeted 
gene mRNAs was normalized to the relative abundance of the housekeeping gene 
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GAPDH. The 2−∆∆Ct method was used to analyse relative changes in gene 
expression (Schmittgen and Livak, 2008).  
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Table 3.1. Primer sequences used in this study. 
Target genes Primer sequences 
CSF-2 Forward 5’CTTCCTGTGCAACCCAGATT 
Reverse 5’CTTGGTCCCTCCAAGATGAC 
GAPDH Forward 5’TGTTGCCATCAATGACCCCTT 
Reverse 5’CTCCACGACGTACTCAGCG 
IFN-α Forward 5’GCCTCGCCCTTTGCTTTACT 
Reverse 5’CTGTGGGTCTCAGGGAGATCA 
IL-12 (p35) Forward 5’CCTTGCACTTCTGAAGAGATTGA 
Reverse 5’ACAGGGCCATCATAAAAGAGGT 
IL-6 Forward 5′GGCACTGGCAGAAAACAACC  
Reverse 5′GCAAGTCTCCTCATTGAATCC 





3.2.6 Detection of CSF-2, IL-12 (p70), IL-6 and IL-8 proteins 
Bioactive IL-12 is secreted as a 70 kDa heterodimeric glycoprotein comprising of 
disulphide-bonded 35 kDa (p35) and 40 kDa (p40) subunits. Therefore, the 
amount of secreted IL-12 protein was quantified using the human IL-12 (p70) 
enzyme-linked immunosorbent assay (ELISA) kit from Biolegend. Similarly, the 
amount of CSF-2, IL-6 and IL-8 proteins in the culture supernatant was quantified 
by ELISA kits from Biolegend. ELISA was performed according to the 
manufacturer’s instructions. Briefly, one day prior to ELISA assay, the 96-well 
MaxiSorp plate was pre-coated with the appropriate capture antibody. The next 
day, the plate was washed and blocked with assay diluent for one hour. A 100 µL 
aliquot of either standards or samples were added to capture antibody pre-coated 
wells and incubated with shaking for two hours at room temperature. The plate 
was washed four times with 300 µL wash buffer per well and blotted to remove 
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residual buffer by firmly tapping plate upside down on absorbent paper. All the 
subsequent washes were performed similarly. Next, 100 µL of detection antibody 
was added to each well for one hour. Plate was washed four times with wash 
buffer. Avidin-conjugated horseradish peroxidase solution (100 µL) was added to 
each well for 30 min prior to washing and substrate addition. Finally, stop 
solution was added and absorbance 450 nm was measured using a microplate 
reader. The cytokine concentrations were determined by interpolation from a 
standard curve and presented as pg/mL. 
 
3.2.7 Detection of IFN-α protein 
The amount of IFN-α protein in the culture supernatant was quantified by ELISA 
kit from R&D Systems. ELISA was performed according to the manufacturer’s 
instructions. Briefly, 100 µL of either standards or samples were added to capture 
antibody pre-coated wells and incubated with shaking for one hour at room 
temperature. Plate was washed as described in section 3.2.6. Next, 100 µL of 
detection antibody was added to each well for 1 h. Plate was washed four times 
with wash buffer. A 100 µL aliquot of avidin-conjugated horseradish peroxidase 
solution was added to well for one hour prior to washing and substrate addition. 
Finally, stop solution was added and absorbance 450 nm was measured using a 
microplate reader. The cytokine concentrations were determined by interpolation 





3.2.8 Cell treatment   
Periodontal fibroblasts were pre-treated with SB203580 (5 µM) or BAY 11-7082 
(5 µM) for 1 h prior to addition of 2 mM NaHS for 24 h, after which ELISA was 
carried out as described in section 3.2.6. The final DMSO amount in these 
treatments was less than 0.1% of the total volume. DMSO controls were included 
in each experiment. 
 
3.2.9 Western blotting 
Periodontal fibroblasts were pre-treated with SB203580 (5 µM) for 1 h prior to 
addition of NaHS for indicated time point and were washed 3 times with 
phosphate-buffered saline (PBS) prior to lysis with M-PER Mammalian Protein 
Extraction Reagent (Thermo Scientific) supplemented with 1x protease inhibitor 
(Sigma) and 1x phosphatase inhibitor (Sigma). Proteins (100 µg) were separated 
by a 12% sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-
PAGE), subsequently electrophoretically transferred to a nitrocellulose membrane 
(Millipore) and blocked with 5% skim milk in Tris-buffered saline + 0.1% 
Tween-20 (TBST) for 1 h at room temperature. Membranes were incubated at 4°C 
overnight with the phopho-p38 antibody (Cell Signalling) diluted 1:1000 in 5% 
bovine serum albumin (BSA) dissolved in TBST. After washing in TBST 3 times, 
the membrane was reacted with the species appropriate peroxidase-coupled 
secondary antibody for 1 h at room temperature with gentle agitation (1:1000). 
Next, 1 mL Amersham ECL Chemiluminescent Substrate (GE Healthcare) was 
added to the membrane and incubated for 5 min. Visualization was performed 
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with the enhanced chemiluminescence system, ChemiDoc MP Imaging system 
(Biorad). To ensure equal sample loading, the phopho-p38 antibody probed 
membrane was stripped with stripping buffer at 50°C for 30 min with shaking. 
Membrane was washed 3 times in TBST prior to incubation with α-tubulin 
antibody (Cell signalling) diluted 1:1000 in 5% BSA dissolved in TBST for 1.5 h. 
After washing in TBST 3 times, the membrane was incubated with the species 
appropriate peroxidase-coupled secondary antibody for 1 h at room temperature 
with gentle agitation (1:1000). The subsequent procedures were described as 
above. Densitometry quantification of the immunoblot bands was performed 
using ChemiDoc MP Imaging system and ImageJ densitometry software. 
 
3.2.10 mRNA stability assay 
Following treatment with 2 mM NaHS for 4 h, transcription was blocked by the 
addition of 5 μg/mL actinomycin D (ActD). Total RNAs were isolated at 0, 1, 2, 
and 4 h after ActD treatment (section 3.2.4). IL-6 and IL-8 mRNAs were 
quantified using qPCR as described in section 3.2.5. mRNA decay was 
represented as percent change over time. mRNA half-life was calculated as the 
intercept on the x-axis at 50% decay of the transcript (Mahmoud et al., 2014).  
 
3.2.11 Bacterial strains and culture conditions 
F. nucleatum, P. gingivalis, T. denticola and T. forsythia were maintained and 
cultured as described in section 2.2.1. Overnight bacteria cultures were pelleted 
by centrifugation at 10,000 x g for 10 min. Bacterial pellets were washed 3 times 
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in sterile PBS to remove residual culture media. Heat inactivation was carried out 
by resuspending the bacterial pellet in sterile DMEM and heated at 80°C for 30 
min. Bacterial suspensions were stored in single use aliquot at -70°C. Heat 
inactivation was confirmed by plating an aliquot of the bacterial suspension on 
their respective growth media (section 2.2.1). 
 
3.2.12 Bacterial stimulation 
Periodontal fibroblasts were stimulated with heat killed F. nucleatum, P. 
gingivalis, T. denticola and T. forsythia at multiplicity of infection (MOI) of 50:1 
(bacteria: cells) and treated with PAM (1 µg/mL) or LPS (1 µg/mL) for 8 h after 
which culture media were collected for ELISA assay (section 3.2.6). 
 
3.2.13 Transfection and reporter assay 
NF-κB secreted alkaline phosphatase (SEAP) reporter vector (Appendix II) was 
purchased from Clontech. This reporter vector possesses the κB regulator factor 
binding site upstream of the SEAP. Changes in cellular NF-κB activity can be 
determined through assaying SEAP enzymatic activity. One day prior to 
transfection, periodontal fibroblasts (1.0 x 104 cells/well) were seeded in a 96-
well flat-bottom microtiter plate in DMEM complete media and allowed to adhere 
overnight. Periodontal fibroblasts were transfected with 100 ng NF-κB SEAP 
plasmid diluted in serum free DMEM with a liposome-based transfection reagent, 
Transfectin (BioRad) for 7 h. Transfection media was removed and replaced with 
DMEM complete media and incubated overnight. Next day, media was replaced 
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with fresh DMEM complete media. Periodontal fibroblasts were stied with 
bacteria as described in section 3.2.12. Culture supernatants were collected and 
subjected to SEAP activity assay using the Phospha-Light assay kit (Applied 
Biosystems) according to the manufacturer’s protocol. 
 
3.2.14 Reduced glutathione (GSH) and oxidized glutathione (GSSG) assay 
Periodontal fibroblasts were stimulated with heat killed F. nucleatum, P. 
gingivalis, T. denticola and T. forsythia at MOI of 50:1 and treated with PAM (1 
µg/mL) or LPS (1 µg/mL) for 4 h. Cells were rinsed twice with PBS after which 
the intracellular GSH and GSSG concentrations were determined using the 
GSH/GSSG-Glo assay kit (Promega) according to manufacturer’s instructions. 
 
3.2.15 Statistical analysis 
Data derived from three independent experimental groups in triplicate. Data are 
expressed as mean ± standard deviation. Statistical significance was assessed by 
either Student’s t-test or one-way ANOVA with Tukey post-hoc analysis where 
indicated using the IBM SPSS Statistics 20. Differences between groups were 




3.3.1 Effects of H2S on cell viability 
To determine if H2S affects the viability of primary periodontal fibroblasts, cells 
were treated with NaHS, at concentrations ranging from 0.25-2 mM for 24, 48 
and 72 h. At these concentrations, cell viability did not change significantly over a 




Figure 3.1. The effect of NaHS on cell viability. Periodontal fibroblasts were 
treated with the indicated concentrations of NaHS for 24, 48 and 72 h after which 
MTS assay was carried out to determine the viability of periodontal fibroblasts. P 
> 0.05 compared to their respective control (without NaHS treatment) at the 


























3.3.2 H2S alone induced the expression of inflammatory mediators in periodontal 
fibroblasts 
To determine the effects of H2S on the expression of genes involved in innate 
immune responses in periodontal fibroblasts, the toll-like receptor signalling PCR 
array (SA Bioscience) was used to determine changes in the expression levels of 
TLRs, NF-κB, cytokine and chemokine genes following treatment of periodontal 
fibroblasts with 2 mM NaHS. Out of the 84 genes examined, 6 genes were 
significantly up-regulated compared to untreated cells (control) (fold change >2). 





Table 3.2. Fold change of genes examined using PCR array analysis between 
control and H2S-treated periodontal fibroblasts. 





Bruton agammaglobulinemia tyrosine kinase 1.00±0.06 
Caspase 8, apoptosis-related cysteine peptidase -1.06±0.07 
Chemokine (C-C motif) ligand 2 1.02±0.03 
CD14 molecule -1.14±0.02 
CD180 molecule 1.00±0.08 
CD80 molecule 1.00±0.07 
CD86 molecule 1.00±0.08 
Conserved helix-loop-helix ubiquitous kinase -1.02±0.05 
C-type lectin domain family 4, member E 1.00±0.04 
Colony stimulating factor 2 (granulocyte-macrophage) 11.09±0.81** 
Colony stimulating factor 3 (granulocyte) 1.00±0.09 
Chemokine (C-X-C motif) ligand 10 1.00±0.07 
ECSIT homolog (Drosophila) -1.01±0.05 
Eukaryotic translation initiation factor 2-alpha kinase 2 1.00±0.07 
ELK1, member of ETS oncogene family -1.06±0.08 
Fas (TNFRSF6)-associated via death domain -1.31±0.01 
FBJ murine osteosarcoma viral oncogene homolog 1.96±0.09 
High mobility group box 1 -1.04±0.05 
V-Ha-ras Harvey rat sarcoma viral oncogene homolog 1.05±0.06 
Heat shock 70kDa protein 1A -1.32±0.13 
Heat shock 60kDa protein 1 (chaperonin) 1.00±0.05 
Interferon, alpha 1 6.81±0.45** 
Interferon, beta 1, fibroblast 1.00±0.06 
Interferon, gamma 1.00±0.05 
Inhibitor of kappa light polypeptide gene enhancer in B-cells, 
kinase beta 1.25±0.08 
Interleukin 10 1.00±0.05 
Interleukin 12A (natural killer cell stimulatory factor 1, 
cytotoxic lymphocyte maturation factor 1, p35) 3.49±0.18** 
Interleukin 1, alpha -1.26±0.05 
Interleukin 1, beta 1.00±0.08 
Interleukin 2 1.00±0.06 
Interleukin 6 (interferon, beta 2) 10.68±0.29** 
Interleukin 8 19.66±0.90** 
Interleukin-1 receptor-associated kinase 1 -1.46±0.12 
Interleukin-1 receptor-associated kinase 2 1.16±0.85 
Interleukin-1 receptor-associated kinase 4 -1.27±0.05 
Interferon regulatory factor 1 1.14±0.02 
Interferon regulatory factor 3 1.06±0.05  
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Jun proto-oncogene 1.26±0.07 
Lymphotoxin alpha (TNF superfamily, member 1) 1.05±0.07 
Lymphocyte antigen 86 1.00±0.06 
Lymphocyte antigen 96 1.10±0.05 
Mitogen-activated protein kinase kinase 3 3.09±0.65** 
Mitogen-activated protein kinase kinase 4 1.22±0.08 
Mitogen-activated protein kinase kinase kinase 1 -1.83±0.05 
Mitogen-activated protein kinase kinase kinase 7 1.17±0.06 
Mitogen-activated protein kinase kinase kinase kinase 4 1.16±0.08 
Mitogen-activated protein kinase 8 1.27±0.07 
Mitogen-activated protein kinase 8 interacting protein 3 -1.09±0.05 
Myeloid differentiation primary response gene (88) -1.08±0.02 
Nuclear factor of kappa light polypeptide gene enhancer in B-
cells 1 1.13±0.04 
Nuclear factor of kappa light polypeptide gene enhancer in B-
cells 2 (p49/p100) 
 
1.59±0.01 
Nuclear factor of kappa light polypeptide gene enhancer in B-
cells inhibitor, alpha 1.01±0.04 
Nuclear factor of kappa light polypeptide gene enhancer in B-
cells inhibitor-like 1 -1.75±0.02 
Nuclear factor related to kappaB binding protein -1.06±0.08 
Nuclear receptor subfamily 2, group C, member 2 -1.06±0.09 
Pellino homolog 1 (Drosophila) 1.27±0.10 
Peroxisome proliferator-activated receptor alpha 1.00±0.05 
Protein kinase, interferon-inducible double stranded RNA 
dependent activator -1.07±0.06 
Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H 
synthase and cyclooxygenase) 1.61±0.45 
V-rel reticuloendotheliosis viral oncogene homolog (avian) 1.38±0.02 
V-rel reticuloendotheliosis viral oncogene homolog A (avian) 1.30±0.05 
Receptor-interacting serine-threonine kinase 2 1.84±0.08 
Sterile alpha and TIR motif containing 1 -1.27±0.09 
Single immunoglobulin and toll-interleukin 1 receptor (TIR) 
domain 1.00±0.06 
TGF-beta activated kinase 1/MAP3K7 binding protein 1 -1.14±0.07 
TANK-binding kinase 1 1.32±0.08 
Toll-like receptor adaptor molecule 1 1.04±0.06 
Toll-like receptor adaptor molecule 2 -1.27±0.06 
Toll-interleukin 1 receptor (TIR) domain containing adaptor 
protein -1.53±0.05 
Toll-like receptor 1 1.66±0.04 
Toll-like receptor 10 1.00±0.08 
Toll-like receptor 2 -1.05±0.05 
Toll-like receptor 3 1.15±0.04 
Toll-like receptor 4 1.00±0.02 
Toll-like receptor 5 1.00±0.01 
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Toll-like receptor 6 -1.06±0.08 
Toll-like receptor 7 1.00±0.06 
Toll-like receptor 8 1.00±0.05 
Toll-like receptor 9 1.00±0.08 
Tumor necrosis factor 1.00±0.05 
Tumor necrosis factor receptor superfamily, member 1A 1.10±0.02 
Toll interacting protein -1.07±0.04 
TNF receptor-associated factor 6 1.17±0.08 
Ubiquitin-conjugating enzyme E2N 1.11±0.05 
*Results are expressed as fold change of 2 mM NaHS treatment over control 
(untreated cells) 







3.3.3 Validation of genes 
The expression of CSF-2, IFN-α, IL-12 (p35), IL-6, and IL-8 genes was validated 
by qPCR. Although the mRNA expression of CSF-2, IFN-α and IL-12 (p35) 
showed >2-fold increase following treatment with H2S, protein levels of these 
mediators were below the limit of detection of the ELISA assay. In contrast, IL-6 
and IL-8 showed significant changes at both mRNA and protein levels with NaHS 
treatment (sections 3.3.4 and 3.3.5). 
 
3.3.4 H2S up-regulated IL-6 and IL-8 mRNA expression 
The kinetics of IL-6 and IL-8 mRNA expression was assessed after 4, 8, and 24 h 
post NaHS treatment. H2S induced a dose-dependent increase in IL-6 and IL-8 
mRNA levels (Fig. 3.2A and B). A minimum dose of 0.25 mM NaHS was 
sufficient to obtain significant increases in both IL-6 and IL-8 mRNA level. The 
mRNA expression of IL-6 and IL-8 peaked at 4 h, however IL-6 mRNA 
expression declined significantly at 8 h post-treatment. At 24 h, the mRNA levels 















Figure 3.2. The effect of NaHS on IL-6 and IL-8 mRNA expression in 
periodontal fibroblasts. (A) IL-6 and (B) IL-8 mRNA from periodontal 
fibroblasts. Cells were treated with the indicated concentrations of NaHS for 4, 8, 
and 24 h. *P < 0.05, **P < 0.01, ***P < 0.001 compared to their respective 






























































































































































3.3.5 H2S elicited IL-6 and IL-8 secretion in periodontal fibroblasts 
To determine if H2S exposure significantly induces IL-6 and IL-8 levels, 
periodontal fibroblasts were treated with NaHS at concentrations ranging from 0.1 
to 2 mM for 24 h, after which culture supernatants were collected and protein 
levels were quantified by ELISA. H2S induced a dose-dependent increase in IL-6 
and IL-8 (Fig. 3.3A and B). A minimum dose of 0.25 mM NaHS was sufficient to 
obtain significant increase in IL-8 whereas a higher dose of NaHS at 0.5 mM was 























Figure 3.3. The effect of NaHS on IL-6 and IL-8 levels produced by periodontal 
fibroblasts. (A) IL-6 and (B) IL-8 from periodontal fibroblasts. Cells were treated 
with increasing amounts of NaHS ranging from 0.1 mM to 2 mM. The culture 
supernatants were collected after 24 h incubation following treatments and the 
amount of IL-6 and IL-8 determined by ELISA. *P < 0.05, ***P < 0.001 










































3.3.6 H2S alone induced IL-6 and IL-8 production in periodontal fibroblasts via 
p38 MAPK signalling 
Two major signalling pathways, namely the mitogen-activated protein kinases 
(MAPK) and nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-
κB) play essential roles in the activation of many pro-inflammatory genes (Karin, 
2004; Siebenlist et al., 1995). To determine the signalling pathway(s) which 
mediate H2S up-regulation of IL-6 and IL-8, cells were pre-treated with either the 
SB203580 (an inhibitor of p38 MAPK pathway) or BAY 11-7082 (an inhibitor of 
NF-κB activation) 1 h prior to NaHS treatment. H2S-mediated IL-6 and IL-8 
increase were obliterated in the presence of SB203580 but not BAY 11-7082 




















Figure 3.4. Signalling pathways responsible for H2S-induced IL-6 and IL-8 levels 
in periodontal fibroblasts. Cells were pre-treated with the vehicle control 
(DMSO), SB203580 (5 M) or BAY-11-7082 (5 μM) for 1 h after which the cells 
were treated with 2 mM NaHS for 24 h. The culture supernatant were collected 
and amount of (A) IL-6 and (B) IL-8 were quantified by ELISA. ***P < 0.001 


































3.3.7 H2S activated p38 MAPK phosphorylation 
The level of p38 MAPK phosphorylation was determined in untreated (control) 
and NaHS treated periodontal fibroblasts by Western blot. Phosphorylation of p38 
MAPK significantly increased at 2 h after H2S exposure (Fig. 3.5), while 
SB203580 treatment significantly reduced H2S-mediated phosphorylation of p38 




Figure 3.5. The effect of NaHS on p38 MAPK phosphorylation in periodontal 
fibroblasts. (A) Cells were exposed to 2 mM NaHS for 1 or 2 h after which cell 
lysates were obtained and subjected to western blot analysis using phospho-p38 
MAPK antibody. α-tubulin served as the loading control. (B) Quantitative 
densitometry analysis was carried out using ImageJ. ***P < 0.001 compared to 














































Figure 3.6. Effect of SB203580 on H2S-induced p38 MAPK phosphorylation. (A) 
Periodontal fibroblasts were pre-treated with vehicle control (DMSO) or 
SB203580 (5 M) for 1 h after which the cells were treated with 2 mM NaHS for 
2 h. Cell lysates were obtained and subjected to western blot analysis using 
phospho-p38 MAPK antibody. α-tubulin served as the loading control. (B) 
Densitometry quantification of the immunoblot bands was performed with 









































3.3.8 Effects of H2S on IL-6 and IL-8 transcript stability is p38 MAPK dependent 
To determine if H2S-mediated p38 MAPK activation influences IL-6 and IL-8 
transcript stability, actinomycin D chase experiment was carried out. Actinomycin 
D was added 4 h after NaHS treatment to block further transcription. At 0, 1, 2 
and 4 h after actinomycin D treatment, the amounts of remaining IL-6 and IL-8 
transcripts were quantified by qPCR.  H2S significantly enhanced the stability of 
IL-6 and IL-8 mRNA after transcription was halt. Treatment with the p38 MAPK 
inhibitor (SB203580) resulted in the abolishment of H2S-mediated enhancement 






















Figure 3.7. Effect of NaHS on stability of IL-6 and IL-8 mRNA in periodontal 
fibroblasts. Cells were pre-treated with the vehicle control (DMSO) and SB 
203580 (5 M) for 1 h, after which the cells were treated with 2 mM NaHS for 4 
h. Subsequently, cells were treated with actinomycin D to block further 
transcription. Total RNA was isolated at 0, 1, 2, 4 h after actinomycin D 
treatment. The remaining (A) IL-6 and (B) IL-8 mRNA was quantified by qPCR. 
*P < 0.05, **P < 0.01, ***P < 0.001 compared to their respective control 

























































TControl1/2 < 48 min 
TNaHS1/2   > 72 min 
TControl1/2 < 48 min 




3.3.9 H2S inhibited TLR-mediated pro-inflammatory response in periodontal 
fibroblasts 
The activation of NF-κB has been implicated in the regulation of transcription of 
a variety of inflammatory genes and has been shown to be the major downstream 
effector of TLR activation (O'Neill et al., 2013). In addition, intracellular thiol 
levels play a key role in regulating these processes (Anderson et al., 1994; Staal et 
al., 1990). Periodontal fibroblasts stimulated with F. nucleatum, P. gingivalis, T. 
denticola, T. forsythia or TLR agonists showed a marked decrease in GSH/GSSG 
ratio (Fig. 3.8A-F), indicating a state of oxidative stress in the cells. Heat-killed 
bacteria or TLR agonists’-stimulated periodontal fibroblasts showed a decrease in 
intracellular GSH/GSSG redox which correlated with the activation of NF-κB 
(Fig. 3.9A-F) and IL-8 increase (Fig. 3.10A-F). H2S alone did not significantly 
alter cellular GSH/GSSG ratio. However, in the presence of TLR activation, H2S 
restored GSH/GSSG ratio (Fig. 3.8A-F), which corresponded with reduced NF-
























































































































Figure 3.8. Effect of NaHS on GSH/GSSG ratios in periodontal fibroblasts 
stimulated with either heat-killed periodontal bacteria or TLR agonists. 
Periodontal fibroblasts were stimulated with heat killed (A) F. nucleatum, (B) P. 
gingivalis, (C) T. denticola and (D) T. forsythia at MOI of 50:1 for 4 h, in the 
absence (control) or presence of NaHS (2 mM) treatment. Periodontal fibroblasts 
were also treated with (E) TLR2 agonist, PAM3CSK4 (PAM) (1 µg/mL) or (F) 
TLR4 agonist, ultra-pure LPS (1 µg/mL) alone or with NaHS treatment (2 mM) 
for 4 h. *P < 0.05, **P < 0.01, ***P < 0.001 compared to their respective control 














































































































































































































































Figure 3.9. Effect of NaHS on TLR-mediated NF-κB activation in periodontal 
fibroblasts. Periodontal fibroblasts transfected with the NF-κB-SEAP reporter 
plasmid were stimulated with heat killed (A) F. nucleatum, (B) P. gingivalis, (C) 
T. denticola and (D) T. forsythia at MOI of 50:1 for 8 h, in the absence (control) 
or presence of NaHS (2 mM). Periodontal fibroblasts were also treated with (E) 
PAM (1 µg/mL) or (F) LPS (1 µg/mL) alone or with NaHS treatment (2 mM) for 
8 h. *P < 0.05, **P < 0.01, ***P < 0.001 compared to their respective control 





























































































































































































Figure 3.10. Effect of NaHS on TLR-mediated IL-8 production in periodontal 
fibroblasts. Periodontal fibroblasts stimulated with heat killed (A) F. nucleatum, 
(B) P. gingivalis, (C) T. denticola and (D) T. forsythia at MOI 50:1 for 8 h, in the 
absence (control) or presence of NaHS (2 mM). Periodontal fibroblasts were also 
treated with (E) PAM (1 µg/mL) or (F) LPS (1 µg/mL) alone or with NaHS 
treatment (2 mM) for 8 h. The amount of IL-8 in the culture supernatant was 
determined by ELISA. **P < 0.01, ***P < 0.001 compared to their respective 









































In mammalian systems, H2S derived from cells is regulated at very low levels by 
three enzymes namely CSE, CBS and 3MST. In health, low levels of H2S have 
been demonstrated to regulate a wide range of physiological functions in various 
organs, such as heart, lung, brain that are discussed in section 1.5. In periodontal 
disease, H2S is produced by periodontal disease-associated bacteria through 
metabolism of sulphur-containing amino acids found either in GCF or produced 
from the proteolytic breakdown of host macromolecules (Persson et al., 1990). 
Given that the amounts of these bacteria increase with increasing probing depth, it 
can be expected that concentrations of H2S increase with severity of periodontal 
disease (Torresyap et al., 2003). In fact, higher levels of H2S have been reported 
in diseased pockets (probing depth >5 mm) compared to healthy ones (probing 
depth ≤3 mm) (Morita and Wang, 2001b). Studies have demonstrated that H2S at 
concentrations lower than those encountered in subgingival plaque was sufficient 
to induce caspase-mediated apoptosis and radical-mediated genomic DNA 
damage in human gingival fibroblasts and gingival epithelial cells (Calenic et al., 
2010; Yaegaki et al., 2008). Similar results were also observed in Chinese 
hamster ovary (CHO) cells where sulphide concentration as low as 250 μM 
caused significant DNA strand breaks, suggesting that H2S may be carcinogenic 
(Attene-Ramos et al., 2006). Interestingly, our study showed that periodontal 
fibroblast was resistant to H2S at concentrations up to 2mM, which is the highest 
concentration so far reported in the subgingival plaque of patients with 
periodontal disease (Persson, 1992). The mechanism of H2S detoxification in 
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periodontal fibroblast is unknown. However, colonocytes that are frequently 
exposed to µM to mM quantities of H2S from sulphate-reducing gut bacteria 
(Blachier et al., 2010), are equipped with mechanism to catabolize H2S. The most 
well studied enzyme involved in H2S detoxification is sulphide:quinone 
oxidoreductase (SQR) that oxidizes H2S to generate non-toxic sulfate (SO4
2-), 
which is subsequently excreted from the body. Conversely, this sulphide 
oxidizing activity was not detectable in brain and neuronal cells (Lagoutte et al., 
2010; Mimoun et al., 2012). Thus, periodontal fibroblasts which are located in 
close proximity to subgingival plaque biofilms which harbour large amounts of 
H2S producing anaerobes (Fig. 3.11) could be equipped with the similar H2S 
detoxification mechanism.  
 
 
Figure 3.11. Periodontal fibroblast is the attaching apparatus that fastens the teeth 
to the jaw bones. Arrow shows the anatomical niche of periodontal fibroblast 
which is located near to the subgingival plaque biofilm. Adapted and modified 
from Hajishengallis, G. (2015). Periodontitis: from microbial immune subversion 
to systemic inflammation. Nature Reviews Immunology, 15(1), 30-44. Figure was 




Out of the 84 genes analysed, H2S induced significant up-regulation of IL-6 and 
IL-8 at the mRNA and protein levels. These effects were found to occur via the 
p38 MAPK signalling rather than the NF-κB pathway (Fig. 3.4). The 3-fold 
increase in the expression of mitogen-activated protein kinase kinase (MKK)-3 
(Table 3.2), which is the upstream activator of p38 (Enslen et al., 1998) further 
corroborates the data that H2S activates the p38 MAPK signalling pathway. 
Similarly, in fibroblast-like synoviocytes, PGE2, IL-8, IL-1α, IL-1β and TNF-α 
were dose dependently elevated by NaHS treatment mediated via MAPK 
signalling but independent of the NF-κB pathway (Stuhlmeier et al., 2009). The 
authors showed that H2S was unable to induce phosphorylation and degradation 
of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor 
(IκB), an inhibitor protein that complexes with NF-κB, subsequently inhibiting 
the translocation of NF-κB into nucleus to activate transcription of genes (Fig. 
3.14). 
 
Cytokine production is modulated at various stages of gene expression, including 
transcription, mRNA export, post-transcriptional and translational levels 
(Palanisamy et al., 2012). The p38 MAPK pathway plays a pivotal role in the 
regulation of inflammatory cytokine and chemokine gene expression both at the 
transcriptional and post-transcriptional levels (Clark et al., 2003; Kirkwood and 
Rossa Jr, 2009; Patil and Kirkwood, 2007). Upon phosphorylation of p38 MAPK, 
downstream intermediates such as MAPKAPK-2 (MK2) becomes 
phosphorylated. This, in turn, activates gene transcription and elicits stabilization 
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of the adenine and uridine (AU)-rich element (ARE), located in the 3’ 
untranslated region (UTR) of transcripts (Fig. 3.12) through trans-acting RNA 
binding proteins (Fig. 3.13) such as tristetraprolin (TTP), human antigen-related 
protein (HuR), butyrate response factor-1 and butyrate response factor-2 (BRF-1 
and BRF-2) (Shim and Karin, 2002). These AREs are the most common 
determinant of RNA stability in mammalian cells which are induced by many 
exogenous factors, including phorbol esters, calcium ionophores, and cytokines 
(Chen and Shyu, 1995). The presence of an ARE site in a particular transcript can 
either target it for rapid degradation or inhibit translation, which is vital to ensure 
rapid and efficient control of expression of cytokines during an infection. In TNF-
α stimulated mouse fibroblasts, cytokine mRNAs that are expressed early, ranging 
from 0.5 h to 6 h have abundant ARE in their 3′ UTR as compared to those 
expressed later (Hao and Baltimore, 2009). In fact, several important 
inflammatory cytokines such as TNF-α, IL-6, IL-8, and cyclooxygenase-2 (COX-
2) were shown to be highly regulated via their AREs (Palanisamy et al., 2012). In 
this study, we showed that H2S enhances the stability of IL-6 and IL-8 transcripts 
by >2-fold (Fig. 3.7A and B). This is the first demonstration that H2S-mediated 




Figure 3.12. Schematic diagram of a typical protein coding mRNA in mammalian 
cells. (A) The 5´terminal 7-methylguanylate (m7G) cap is present on most 
eukaryotic mRNAs to protect mRNA against exonuclease degradation followed 
by coding region that acts as a template for protein synthesis. The 3′-untranslated 
region (UTR) harbours multiple ARE repeats that can be regulated post-
transcriptionally. The 3′UTR dictates mRNA turnover and polyadenylated at the 







Figure 3.13. Proposed mechanisms for H2S-mediated IL-6 and IL-8 transcript 
stability via p38 MAPK/MK2 signalling axis. H2S stimulates p38 MAPK 
phosphorylation via signalling intermediate, such as MKK3. p38 MAPK activates 
MK2 in the nucleus, allowing for MK2 to translocate to the cytoplasm. The newly 
synthesized transcript is rapidly stabilised by interacting with RNA binding 
proteins such as TTP, HuR, BRF-1 and BRF-2, activated by MK2 at the ARE 
located in 3’ UTR.  
 
IL-6 is a multifunctional cytokine, has a number of biological activities, including 
B-lymphocyte differentiation, T-lymphocyte proliferation and the stimulation of 
immunoglobulin (Ig) secretion by B-lymphocytes (Hirano et al., 1990). In 
particular, IL-6 induces bone resorption by itself or functions in concert with 
other bone-resorbing mediators such as IL-1α, IL-1β, TNF-α, and LPS (Ishimi et 
al., 1990). Overproduction of IL-6 therefore contributes to alveolar bone loss that 
supports the tooth. IL-8 is a key chemokine responsible for the chemotactic 
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migration and activation of neutrophils and other cell types (such as monocytes, 
lymphocytes, basophils, and eosinophils) to the site of infection (Miller and 
Krangel, 1991; Negus, 1996). IL-8 activates neutrophils by up-regulating cell-
surface adhesion molecule expression such as endothelial leukocyte adhesion 
molecule (ELAM-1) and intracellular adhesion molecule (ICAM-1), thereby 
enhancing neutrophil adherence to endothelial cells (Warren, 1990) and 
facilitating their diapedesis through vessel walls. IL-8 mediates the recruitment 
and activation of neutrophils in inflamed tissue and therefore plays a crucial role 
in the first line of host defence against microorganisms (Baggiolini et al., 1989; 
Huber et al., 1991). However, the ability of IL-8 to recruit leukocytes and 
potentiate or prolong the inflammatory response may have profound implications 
for the progression of periodontal disease, where tissue destruction may be 
widespread.  In fact, both IL-6 and IL-8 are frequently detected in GCF from 
patients with periodontal disease, while removal of the bacterial plaque during 
periodontal therapy significantly reduced the total amount of IL-6 and IL-8 in 
GCF (Dongari-Bagtzoglou and Ebersole, 1998; Gamonal et al., 2000; Geivelis et 
al., 1993; Goutoudi et al., 2011; Konopka et al., 2012; Reis et al., 2014).  
 
First evidence for the presence and role of reactive oxygen species (ROS) in the 
periodontium was given by the detection of these molecules after respiratory burst 
by polymorphonuclear leukocytes in periodontal damage (Chapple and Matthews, 
2007). Increasingly, ROS production and cellular redox imbalance are implicated 
in the pathogenesis of periodontal disease. Patients with periodontal disease 
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demonstrate higher lipid peroxidation (an end product of oxidative stress), in 
saliva, than healthy subjects (Guentsch et al., 2008). In vitro, vitamin C was found 
to protect human gingival fibroblasts from the cytotoxic effects of P. gingivalis 
infection which involved superoxide production (Staudte et al., 2010). ROS was 
shown to be associated with activation of the redox-sensitive transcription factor 
NF-κB (Jun et al., 2007). NF-κB plays a major role in governing the expression of 
pro-inflammatory cytokines and chemokines in receptor-activated gingival and 
periodontal fibroblasts (Herath et al., 2013; Liu et al., 2014; Vardar-Sengul et al., 
2009). Hydrogen peroxide (H2O2) and ultraviolet (UV)-elicited NF-κB activation 
are often used as models of this common redox regulation (Schreck et al., 1991) 
providing a direct molecular link between oxidative imbalance and inflammation 
(Gloire et al., 2006; Schreck et al., 1991). In fact, H2O2 at 2.5–5 μM was 
demonstrated to trigger NF-κB nuclear translocation in periodontal fibroblasts and 
subsequently increase levels of soluble chemokine (C-X-C motif) ligand 12 
(CXCL12), IL-6, IL-8 (Lee et al., 2008) and vascular endothelial growth 
factor  (VEGF) (Cavalla et al., 2015).  
 
GSH is the most abundant and important intracellular thiol redox regulator. It is 
able to scavenge hydroxyl (HO·) and singlet oxygen directly by reaction with its 
thiol group. High intracellular GSH levels could influence protein folding or 
enzyme activation via its action on the active thiol moieties of proteins 
(Anderson, 1998) and thus block the activation of the protein kinases, for 
instance, inhibitor of the nuclear factor-κB kinase complex (IκB kinase complex) 
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that phosphorylates IκB/NF-κB complex and liberates activated NF-κB (Fig. 
3.14A and B). Alternatively, GSH could also interfere directly with IκB 
phosphorylation or with the transport of activated NF-κB into the nucleus to 
initiate transcription (Fig. 3.14A and B). On the other hand, NF-κB signalling has 
been shown to be enhanced via elevated intracellular levels of GSSG or increase 
GSSG/GSH ratios by the inhibition of glutathione reductase (GR) activity (Fig. 
2.25) in phorbol myristate acetate (PMA)-stimulated T-lymphoblast (Galter et al., 
1994). Furthermore, Droge et al. showed that in T-lymphoblast, H2O2 induced 
NF-κB activity via elevated intracellular GSSG levels through GPx reaction (Fig. 






Figure 3.14. Overview of TLR-mediated NF-κB signalling. In unstimulated cells, 
NF-κB is sequestered in the cytosol through interactions with IκB. (A) TLR-
mediated cell activation enhances the activity of IκB kinase complex. This leads 
to degradation of the IκB through the ubiquitination-proteosome pathway and 
release of transcription factor NF-κB, which translocates into the nucleus and 
activates the transcription of genes containing κB regulatory element. (B) 






Here, we showed a decrease of GSH/GSSG ratios in periodontal fibroblasts 
stimulated with F. nucleatum, P. gingivalis, T. denticola, T. forsythia or treated 
with TLR2 or TLR4 agonists. This implies TLR activation induced a state of 
oxidative stress in cells and corresponding activation of NF-κB. Notably, 
treatment with either F. nucleatum or TLR2 agonist resulted in the most 
significant perturbations in intracellular GSH levels as well as activation of NF-
κB signalling. Intriguingly, H2S restored GSH/GSSG redox in these conditions 
and correspondingly also rescued NF-κB activation and IL-8 production. This 
phenomenon could be attributed to the ability of H2S to maintain intracellular 
redox homeostasis through its reducing property or via enzymatic means. In 
cardiomyocytes, H2S activated superoxide dismutase (SOD) activity to detoxify 
ROS during hypoxia-reoxygenation (H/R) condition (Sun et al., 2012). H2S was 
demonstrated to protect against a severe cerebral injury induced by a global 
cerebral ischaemia-reperfusion (I/R) possibly through the inhibition of NADPH 
oxidase, the enzyme complex responsible for the production of ROS,  and 
increase of SOD activity in the brain tissues (Yin et al., 2013). H2S was also 
found to protect against hyperglycemia-induced oxidative stress in 
cardiomyocytes via activation of nuclear factor erythroid 2-related factor 2 (Nrf2), 
the major transcription factor that regulates the expression of antioxidant 
proteins, and up-regulated expression of SOD (Yang et al., 2015). More 
importantly, H2S is found to augment intracellular GSH levels in glutamate-
induced oxidative stress in neuronal cells and monocytes exposed to high glucose 
levels (Jain et al., 2014; Kimura et al., 2010). Treatment with NaHS could also 
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decrease GSSG levels in the lung tissues and thus relieve oxidative stress 
occurring during the development of hypoxic pulmonary hypertension (Wei et al., 
2008). 
 
Thus, in the absence of TLR stimulation, H2S exerted pro-inflammatory effects on 
periodontal fibroblast by eliciting IL6 and IL8 production through stabilising 
mRNA in p38 MAP kinase-mediated pathway. In contrast, H2S exerted anti-
inflammatory effect on periodontal fibroblast by restoring GSH/GSSG ratios, 
which corresponded with reduced NF-κB activation following TLR stimulation. 
These findings suggest that H2S is not just a metabolic by-product of periodontal 
anaerobes, but rather a potentially important virulence attribute of these bacterial 
species. During the early stages of infection, H2S could enhance the survival of 
periodontal anaerobes by creating a localized environment which is low in oxygen 
tension and to protect these organisms from periods of oxidative stress. 
Furthermore, H2S-mediated inflammation could serve as a means for these 
bacteria to obtain nutrients from the breakdown of host macromolecules. Once 
H2S producing bacteria have established their niche in the periodontal pocket, H2S 
could serve as a means to down-regulate the host immune response so as to 
establish a state of chronic infection, facilitating their survival and persistence in 














This chapter presents the potential implications of the findings obtained from this 
study. In addition, limitations in the methodology employed and potential future 
work are discussed.  
 
Microbial and host response act in concert contributing to the pathogenesis of 
periodontal disease (Khan et al., 2015). The microbial factor contributing to 
periodontal disease is the change in the composition of the oral microflora, while 
the host factor is bacteria-induced chronic host inflammatory response. In this 
study, H2S which has long been associated with periodontal disease was 
demonstrated to potentially impact both microbial and host immune response of 
the disease. The primary goal of periodontal treatment is to restore the 
homeostatic relationship between periodontal tissue and dental plaque community 
(Darveau, 2010). Scaling and root planing (SRP) is the gold standard for 
treatment of periodontal disease. SRP involves mechanical debridement to 
remove microbial plaque and calculus using a powered ultrasonic or sonic scaler. 
However, SRP  alone may not produce the desired clinical outcomes in severe 
cases such as deep periodontal pockets or in patients with recurrence of disease 
who fail to stabilise following mechanical therapy (Berezow and Darveau, 2011). 
Adjunctive antimicrobials such as chlorhexidine and administration of systemic 
antibiotic for example amoxicillin and/or metronidazole are sometimes used in 
addition to SRP that aim at eradicating or controlling specific pathogens (Canas et 
al., 2015). Nevertheless, the adjunctive use of local or systemic antibiotics and 
antiseptics improves the outcome of periodontal therapy only temporarily. This is 
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evidenced in a study that showed reductions in probing depth were significant for 
the first 3 months after antimicrobial application but did not remain significant at 
the 6-month visit since a variety of microbes with differing antimicrobial 
susceptibility profiles may arise (Kinane and Radvar, 1999; Quirynen et al., 
2002). Furthermore, the burgeoning rise in multi-drug resistant bacteria 
incidences call for the development of approaches that do not rely on antibiotics. 
 
With advances in sequencing technology, it is evident that dysbiosis of plaque 
microflora occurs during periodontal disease. The use of probiotics has proven to 
be effective in treating inflammatory bowel disease, a chronic inflammatory 
disorder of the gut, which is also attributed to disturbances in gut microflora 
haemostasis (Geier et al., 2007; Nomoto, 2005; Reid et al., 2003; Weng and 
Walker, 2006). This led to interest in the use of probiotics as an adjunct to SRP in 
periodontal therapy. So far, clinical trials have shown that the use of a mouth rinse 
containing probiotics Bacillus subtilis (Tsubura et al., 2009) or oral administration 
of tablets containing Lactobacillus reuteri for 14 days (Iniesta et al., 2012) are 
able to reduce the number of periodontal pathogens. However, the effects of 
probiotics as an adjunct therapy may only be transient as these bacteria are not 
indigenous residents of the oral cavity. Most evidence so far indicate that 
consumption of probiotics do not render these probiotic bacteria to become 
permanent resident of the gastrointestinal microbiota. A number of studies 
investigating oral colonisation following probiotic ingestion also found similar 
patterns where ingested lactobacilli colonised only transiently and disappeared 
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soon after administration of the probiotic ended (Busscher et al., 1999; Petti et al., 
2001; Yli‐Knuuttila et al., 2006). Furthermore, it is very difficult to alter the 
composition of established plaque microbial communities in adults as compared 
to individuals who received probiotic therapy at the age of 10 years (Kilian et al., 
2006; Yli‐Knuuttila et al., 2006). More importantly, the use of probiotics carries a 
risk of sepsis, particularly in individuals who are immunocompromised (Husni et 
al., 1997; Salminen et al., 2004), or who suffer from chronic complications such 
as diabetes (Boyle et al., 2006) or short gut syndrome (De Groote et al., 2005). 
For instance, a 48-year-old diabetic woman with diarrhoea attributable 
to Clostridium difficile died from multi-organ failure and septic shock in 
association with a toxic megacolon and probiotic fungaemia after oral treatment 
with probiotic Saccharomyces boulardii (Lestin et al., 2003). Other predisposing 
factors include prior prolonged hospitalisation and prior surgical intervention 
(Salminen et al., 2004). In fact, an individual who had been taking L. rhamnosus 
in a probiotic preparation developed L. endocarditis following dental treatment 
(Mackay et al., 1999).  
 
Teughels et al. suggested deliberate colonization of pockets with oral commensal 
streptococci could be an alternative to the armamentarium of treatment options for 
periodontal disease (Teughels et al., 2007). Indeed, when a mixture of oral 
commensal streptococcal consisting of S. sanguinis, S. salivarius and S. mitis was 
applied to the teeth of canines as an adjunctive therapy following SRP, there was 
a delay in the recolonization of periodontal pathogens, reduction in inflammation, 
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and improved bone density and bone levels (Nackaerts et al., 2008; Teughels et 
al., 2007).  
 
In this study, we showed that H2S could contribute to periodontal disease through 
several ways. H2S not only supported the growth of periodontal pathogens under 
aerobic conditions but differentially elicited bacteriostatic effect to health 
associated oral streptococci which possess low intracellular GSH. Augmentation 
of cellular GSH with NAC led to resistance against H2S. NAC is an acetylated 
variant of the amino acid L-cysteine but possesses higher membrane permeability 
compared to its counterpart. NAC is hydrolysed into a cysteine precursor upon 
entry into cells and is converted enzymatically to GSH (Bavarsad Shahripour et 
al., 2014). Results from our laboratory further showed that periodontal pathogens 
could not metabolize NAC to produce H2S. In humans, administration of NAC 
has been proven to be beneficial in relieving oxidative stress-induced 
complications from diseases such as human immunodeficiency virus (HIV) 
infection, cancer, heart disease, and cigarette smoking (Kelly, 1998). Thus, 
incorporation of NAC into dentifrices and mouth rinses could be a potentially 
beneficial adjunct in periodontal therapy and disease prevention regimens to 
protect oral streptococci against H2S produced by oral pathogens so as to favour 
the survival of health associated oral microflora and reduce colonization with 




In conventional rodents (not germ-free), inflammation and periodontal bone 
destruction were observed when silk ligatures were placed around the teeth. In 
contrast, germ-free rodents are not susceptible to periodontal destruction even 
when silk ligatures were placed around the teeth (Rovin et al., 1966). These 
observations provided evidence that the presence of both local irritation and 
microorganisms are necessary to produce periodontal inflammation. Tanner et al. 
suggested that inflammation fosters the growth of a dysbiotic and pathogenic 
microbiota (Tanner et al., 2007). Microbial communities in subgingival plaque 
proactively induce inflammation and thereby stimulate the flow of GCF, a 
nutritionally rich serum-like exudate to obtain essential nutrients. This hypothesis 
is consistent with experimental data showing that anti-inflammatory treatments 
diminish the periodontal bacteria burden possibly by depriving these bacteria of 
nutrients obtained from inflammatory breakdown of tissue. In a mouse model of 
P. gingivalis-induced periodontal disease, local treatment with a complement C5a 
receptor (C5aR; CD88) antagonist, a potent inflammatory chemoattractant that 
facilitates phagocytosis and clearance of pathogens, reversed inflammation 
through down-regulation of TNF-α, IL-1β, IL-6, and interleukin-17 (IL-17) and 
further protected against bone loss. In that study, P. gingivalis was eradicated by 
the C5aR antagonist treatment (Abe et al., 2012). Moreover, treatment of mice 
undergoing ligature-induced periodontal disease with meloxicam, a nonsteroidal 
anti-inflammatory drug (a selective inhibitor of cyclooxygenase-2) caused a 
significant reduction of the periodontal bacterial load (Eskan et al., 2012). The 
continuous microbial signals emanating from plaque biofilm prevent the immune 
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response from resolving, eventually resulting in damage to the gingiva. In 
addition to tissue damage, several osteoclast-related mediators target the alveolar 
bone, causing bone resorption and demineralization, which result in bone 
destruction. Although the direct pathogenic effects of the bacteria remain unclear 
in vivo, evidence suggest that collateral damage from the host response to the 
infection ultimately destroys the periodontal structures that support the tooth. 
Therefore, treatments aimed at suppressing inflammation or alternatively termed 
as “host modulation therapy” (Reddy et al., 2003) have been proposed to be used 
in combination with SRP in the treatment of periodontal disease. 
 
In this study, H2S induced IL-6 and IL-8 production in periodontal fibroblasts 
through p38 MAPK-dependent enhancement of transcript stability. 
Overproduction of these inflammatory mediators could be detrimental as they can 
recruit more non-resident cells (for example, neutrophils, macrophages, and 
lymphocytes) to infiltrate tissues at the periodontium. An excessive accumulation 
of immune cells could contribute significantly to the development of chronic 
inflammation. This observation identifies p38 MAPK as a target for H2S to elicit 
pro-inflammatory effects on periodontal fibroblasts via production of IL-6 and IL-
8. However, the p38 MAPK pathway also involves in the control of fundamental 
processes including cell proliferation (Han et al., 1994), differentiation (Li et al., 
2000) and migration (Li et al., 2000). Thus, compounds that specifically target 
signalling pathway that regulates cytokines transcript stability such as targeting 
MK2 (Fig. 3.13) may potentially be beneficial as an adjunct in the treatment of 
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chronic inflammatory diseases. On the other hand, we further showed that H2S 
also suppressed TLR-mediated NF-κB activation by restoring GSH/GSSG ratio 
and corresponding down-regulation of IL-8 production in periodontal fibroblasts. 
We propose that H2S could be exploited by oral periodontal pathogens such as F. 
nucleatum, P. gingivalis, T. denticola and T. forsythia as a double-edged sword to 
induce inflammation that provides nutrients and at the same time, control the 
excessive recruitment of neutrophils to the site of infection enhancing their 
survival advantage. These observations suggest that periodontal pathogens can 
utilize H2S as a means to shape the local inflammatory environment and allow 
their persistence in the chronic inflammatory environment of pockets.  
 
In this study, although the experiments were carefully planned and executed to 
test our hypotheses, several methodological limitations exist. Firstly, planktonic 
bacteria were used to determine the effects of H2S on the survival of oral 
streptococci and periodontal anaerobes. In the oral environment however, bacteria 
grow in complex polymicrobial associations also termed biofilms. Biofilms 
exhibit structural and functional heterogeneity that is not observed when the same 
organisms are grown in planktonic culture. For instance, bacteria in biofilms 
exhibit increased tolerance to antimicrobials (Stewart and Franklin, 2008). In 
addition, the number of bacterial species employed in this study does not 
represent the in vivo biofilm microbiota that harbours approximately 700 
different bacterial species (Aas et al., 2005). Thus, future studies involving 
multispecies biofilm can be performed. To do this, an ex vivo plaque-biofilm can 
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be obtained by harvesting plaque biofilm from periodontally healthy individuals. 
The harvested biofilms can be cultured in the presence and absence of NaHS after 
which the amount of surviving bacteria, such as oral streptococci, F. nucleatum or 
P. gingivalis determined by plating on selective media.  
 
An in vitro cell culture model was employed in this study to determine the effects 
of H2S on inflammatory response of periodontal fibroblasts. Although periodontal 
fibroblast is one of the major cell types in the periodontium, nevertheless, other 
cell types for example, leukocytes (Landzberg et al., 2015) may also be found in 
the vicinity of the periodontium, thus potentially modifying the inflammatory 
response against H2S-producing periodontal anaerobes. Nevertheless, results 
obtained from this work provide a basis for future in vivo studies where the effects 
of H2S on periodontal inflammation at an organism level using animal models can 
be carried out. Specifically, germ-free mice may be employed in future 
experiments to examine how the innate immune response to H2S induces 
inflammation at an organism level. NaHS can be injected into the gingival tissue 
surrounding the posterior teeth of the mice. Subsequently, levels of pro-
inflammatory cytokines in GCF can be determined. On the other hand, to test if 
H2S influences the innate immune response to microbial component that induces 
inflammation, LPS injection model can be employed. This model has been well-
characterized to produce a histopathological aspect similar to that observed in 
established periodontal disease in humans. For example, increased infiltration of 
leukocytes to the periodontal tissue, higher levels of pro-inflammatory cytokines 
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in GCFs, collagen degradation, and alveolar bone loss have been demonstrated 
(Graves et al., 2012). Injection of mixtures of NaHS with bacterial LPS into the 
gingival tissue surrounding the posterior teeth of the mice can be performed and 
the degree of inflammation determined by levels of pro-inflammatory cytokines in 
GCFs. 
 
In summary, this work has provided new knowledge and advanced our 
understanding of H2S as a gaseous mediator with potential impact on oral 
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I. Modified NOS Medium 
Brain Heart Infusion (Acumedia)..................................................................1.250 g 
Trypticase Peptone (BD BBL).......................................................................1.000 g  
Yeast Extract (Acumedia)..............................................................................0.250 g  
Sodium thioglycollate (Sigma)......................................................................0.050 g  
L-Cysteine x HCl (Sigma).............................................................................0.100 g  
L-Asparagine (Sigma)....................................................................................0.025 g  
D-Glucose (Sigma)........................................................................................0.200 g  
Deionized Water to.......................................................................................94.0 mL 
Autoclaved at 1210C for 30 min, subsequently the following filter-sterilized 
ingredients were added: 
 
NaHCO3 (7.5% w/v in water) (Sigma)….....................................................2.67 mL 
TPP/VFA Solution (see below)......................................................................2.0 mL 
Foetal bovine serum (Hyclone)......................................................................2.0 mL 
 
TPP-VFA Solution  
Thiamine pyrophosphate (0.2% w/v in water) (Sigma).................................1.5 mL 
VFA Solution (see below)..............................................................................1.0 mL 
Deionized Water.............................................................................................8.4 mL 
VFA Solution  
Isobutyric acid (Sigma)..................................................................................0.5 mL 
2-Methylbutyric acid (Sigma)........................................................................0.5 mL 
Isovaleric acid (Sigma)...................................................................................0.5 mL 
Valeric acid (Sigma).......................................................................................0.5 mL 
0.1 N NaOH to............................................................................................100.0 mL  
xvi 
 
II. Schematic map of plasmid vector pNFκB-SEAP (Clontech) 
 
Figure A1. pNFκB-SEAP is designed for monitoring the activation of NF-κB 
signal transduction pathway. pNFκB-SEAP contains the secreted alkaline 
phosphatase (SEAP) reporter gene. This vector also contains four tandem copies 
of the NF-κB consensus sequence fused to a TATA-like promoter (PTAL) region 
from the Herpes simplex virus thymidine kinase promoter. After endogenous NF-
κB proteins bind to the kappa (κ) enhancer element (κB4), transcription is induced 
and the reporter gene is activated. The SEAP coding sequence is followed by the 
SV40 late polyadenylation signal to ensure proper, efficient processing of the 
SEAP transcript in eukaryotic cells. Located upstream of the κB4 is a synthetic 
transcription blocker (TB), which is composed of adjacent polyadenylation and 
transcription pause sites for reducing background transcription. The vector 
backbone also contains an f1 origin for single-stranded DNA production, a pUC 
origin of replication, and an ampicillin resistance gene for propagation and 
selection in E. coli.   
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Publication: 
Ooi XJ, Tan KS (2016). Reduced glutathione mediates resistance to H2S toxicity 
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1. X.J. OOI and K.S. TAN (2013). Volatile sulphur compound modulates 
inflammatory response in periodontal ligament fibroblasts. J Dent Res 92 (Spec 
Iss B): 181187, Bangkok, Thailand: 2nd International Association for Dental 
Research, Asia Pacific Region (IADR-APR), 2013  
(Oral and poster) 
 
Objective: Microorganisms associated with periodontitis include Porphyromonas 
gingivalis, Tannerella forsythia and Treponema denticola. These bacterial species 
produce volatile sulphur compounds (VSCs) as by-products of anaerobic 
metabolism. VSCs include hydrogen sulphide (H2S), methyl-mercaptan and 
methyl sulphide and are the causative agents of oral malodor. While plaque 
biofilm is necessary to initiate the disease process, inappropriate host 
inflammatory response against biofilm bacteria leads to destruction of the 
periodontium and bone loss. H2S is the main VSCs found in subgingival plaque of 
periodontitis patients. The human periodontal ligament fibroblasts (hPDLFs) is 
the main cell type found in the periodontium and is responsible for the 
maintenance of structural and functional integrity. More recently, hPDLFs have 
been proposed to play important roles in innate immune response against biofilm 
bacteria. In this study, we hypothesize that H2S modulates inflammatory response 
of human periodontal ligament fibroblasts (hPDLFs). 
 
Methods: hPDLFs were treated with either H2S donors (NaHS or GYY) alone or 
combination of H2S donors and P. gingivalis lipopolysaccharide (LPS). The 
amount of interleukin-8 (IL-8) produced following these treatments were 
quantified by enzyme linked immunosorbent assay (ELISA). The effects of NaHS 
or GYY on cell viability were determined by MTS assay. 
 
Results: NaHS or GYY treatments did not exert significant effects on cell 
viability. Exposure of hPDLFs to H2S alone led to significant increase in IL-8. 
Additionally, H2S potentiated the effects of P. gingivalis LPS mediated IL-8 
production in these cells. 
 
Conclusions: IL-8 is a key cytokine involved in the pathology of periodontitis. 
We have found that H2S, a metabolic by-product of periodontal bacteria 
modulates IL-8 production in hPDLFs. This study provides evidence on the 





2. X.J. OOI and K.S. TAN (2014). Hydrogen sulphide modulates interleukin-8 
transcript stability in periodontal ligament fibroblast. J Dent Res 93 (Spec Iss C): 
191849, Sarawak, Malaysia: IADR-SEAADE, 2014 
(Oral)  
 
Objective: Hydrogen sulphide (H2S), a metabolic by-product of periodontal 
anaerobes, is a major contributor of halitosis. It has recently been recognized as a 
gaseous mediator with physiologically diverse functions, including modulation of 
inflammation. Human periodontal ligament fibroblast (PDLF) expresses various 
pattern recognition receptors involved in sensing and initiation of innate immune 
response against bacterial infection. While high concentrations of H2S have been 
reported in periodontal pockets of patients, its potential role in modulating 
immune responses in PDLF has not been explored. Since interleukin-8 (IL-8) is a 
key chemo-attractant of neutrophils during periodontitis, the objective of this 
study was to determine if H2S modulates IL-8 production in PDLF. 
 
Methods: qPCR and ELISA were carried out to quantify the production of IL-8 
mRNA and protein respectively in PDLFs treated with the H2S donor, sodium 
hydrosulphide (NaHS). To determine if H2S-mediated IL-8 production was 
mediated by either p38 MAPK or NF-κB pathways, cells were treated with 
SB203580 and BAY11-7082 respectively. Actinomycin D chase experiment was 
performed to determine if H2S treatment affected the stability of IL-8 transcript. 
The effect of NaHS on cell viability was determined by MTS assay. 
 
Results: H2S did not significantly affect viability of PDLF. Exposure to H2S led to 
significant increase in IL-8 production in a dose-dependent manner. Disruption of 
p38 MAPK and not NF-κB signalling pathway resulted in a significant decrease 
in H2S-mediated IL-8 production. Increased H2S-mediated IL-8 level was found 
to be modulated at level of mRNA stability.  
 
Conclusion: IL-8 is a key cytokine involved in the initiation and progression of 
periodontitis. We show for the first time that H2S modulates IL-8 production in 
PDLFs through p38 MAPK-dependent enhancement of transcript stability. This 









IV. Results for Toll-like receptor signalling PCR array 
Table A1: Cycle threshold (Ct) values of genes examined using PCR array 
analysis for untreated periodontal fibroblasts. 







3 AVE SD 
      
Bruton agammaglobulinemia tyrosine 
kinase 
35.00 35.00 35.00 
35.00 0.00 
Caspase 8, apoptosis-related cysteine 
peptidase 
32.10 30.05 28.00 
30.05 2.05 
Chemokine (C-C motif) ligand 2 32.81 31.81 30.81 31.81 1.00 
CD14 molecule 34.30 33.18 32.06 33.18 1.12 
CD180 molecule 35.00 35.00 35.00 35.00 0.00 
CD80 molecule 35.00 35.00 35.00 35.00 0.00 
CD86 molecule 35.00 35.00 35.00 35.00 0.00 
Conserved helix-loop-helix ubiquitous 
kinase 
30.87 29.44 28.01 
29.44 1.43 
C-type lectin domain family 4, member 
E 
35.00 35.00 35.00 
35.00 0.00 
Colony stimulating factor 2 
(granulocyte-macrophage) 
35.00 35.00 35.00 
35.00 0.00 
Colony stimulating factor 3 
(granulocyte) 
35.00 35.00 35.00 
35.00 0.00 
Chemokine (C-X-C motif) ligand 10 35.00 35.00 35.00 35.00 0.00 
ECSIT homolog (Drosophila) 29.95 28.84 27.73 28.84 1.11 
Eukaryotic translation initiation factor 
2-alpha kinase 2 
29.50 27.40 25.30 
27.40 2.10 
ELK1, member of ETS oncogene 
family 
31.39 29.29 27.19 
29.29 2.10 
Fas (TNFRSF6)-associated via death 
domain 
28.49 27.37 26.25 
27.37 1.12 
FBJ murine osteosarcoma viral 
oncogene homolog 
34.37 33.25 32.13 
33.25 1.12 
High mobility group box 1 27.29 25.18 23.07 25.18 2.11 
V-Ha-ras Harvey rat sarcoma viral 
oncogene homolog 
27.49 27.49 27.49 
27.49 0.00 
Heat shock 70kDa protein 1A 29.49 27.49 25.49 27.49 2.00 
Heat shock 60kDa protein 1 
(chaperonin) 
26.66 24.33 22.00 
24.33 2.33 
Interferon, alpha 1 35.00 35.00 35.00 35.00 0.00 
Interferon, beta 1, fibroblast 35.00 35.00 35.00 35.00 0.00 
Interferon, gamma 35.00 35.00 35.00 35.00 0.00 
Inhibitor of kappa light polypeptide 
gene enhancer in B-cells, kinase beta 
30.80 29.65 28.50 
29.65 1.15 
Interleukin 10 35.00 35.00 35.00 35.00 0.00 
Interleukin 12A (natural killer cell 
stimulatory factor 1, cytotoxic 
lymphocyte maturation factor 1, p35) 




Interleukin 1, alpha 34.90 33.79 32.59 33.76 1.16 
Interleukin 1, beta 35.00 35.00 35.00 35.00 0.00 
Interleukin 2 35.00 35.00 35.00 35.00 0.00 
Interleukin 6 (interferon, beta 2) 34.84 32.84 30.84 32.84 2.00 
Interleukin 8 30.96 28.85 26.74 28.85 2.11 
Interleukin-1 receptor-associated 
kinase 1 
29.68 28.57 27.46 
28.57 1.11 
Interleukin-1 receptor-associated 
kinase 2 30.92 29.81 28.70 29.81 1.11 
Interleukin-1 receptor-associated 
kinase 4 
29.50 28.39 27.28 
28.39 1.11 
Interferon regulatory factor 1 30.92 29.81 28.70 29.81 1.11 
Interferon regulatory factor 3 29.30 27.18 25.06 27.18 2.12 
Jun proto-oncogene 27.66 27.33 27.01 27.34 0.33 
Lymphotoxin alpha (TNF superfamily, 
member 1) 
35.00 35.00 35.00 
35.00 0.00 
Lymphocyte antigen 86 35.00 35.00 35.00 35.00 0.00 
Lymphocyte antigen 96 32.25 29.25 26.25 29.25 3.00 
Mitogen-activated protein kinase 
kinase 3 
29.05 27.03 25.01 
27.03 2.02 
Mitogen-activated protein kinase 
kinase 4 
29.96 28.84 27.72 
28.84 1.12 
Mitogen-activated protein kinase 
kinase kinase 1 
34.22 32.11 30.01 
32.11 2.11 
Mitogen-activated protein kinase 
kinase kinase 7 
27.01 27.07 27.13 
27.07 0.06 
Mitogen-activated protein kinase 
kinase kinase kinase 4 
28.82 26.41 24.00 
26.41 2.41 
Mitogen-activated protein kinase 8 28.00 28.57 29.04 28.54 0.52 
Mitogen-activated protein kinase 8 
interacting protein 3 
30.96 29.85 28.74 
29.85 1.11 
Myeloid differentiation primary 
response gene (88) 
29.01 28.01 27.01 
28.01 1.00 
Nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 1 
32.50 29.39 26.28 
29.39 3.11 
Nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 2 
(p49/p100) 
30.14 29.07 28.00 
29.07 1.07 
Nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 
inhibitor, alpha 
28.02 26.97 25.92 
26.97 1.05 
Nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 
inhibitor-like 1 
29.20 28.20 27.20 
28.20 1.00 
Nuclear factor related to kappaB 
binding protein 
31.49 30.38 29.27 
30.38 1.11 
Nuclear receptor subfamily 2, group C, 
member 2 
29.50 29.52 29.54 
29.52 0.02 
Pellino homolog 1 (Drosophila) 31.80 30.70 29.60 30.70 1.10 




Protein kinase, interferon-inducible 
double stranded RNA dependent 
activator 
29.46 28.23 27.00 
28.23 1.23 
Prostaglandin-endoperoxide synthase 2 
(prostaglandin G/H synthase and 
cyclooxygenase) 
31.27 30.27 29.27 
30.27 1.00 
V-rel reticuloendotheliosis viral 
oncogene homolog (avian) 
33.47 31.27 29.07 
31.27 2.20 
V-rel reticuloendotheliosis viral 
oncogene homolog A (avian) 




30.66 28.36 26.06 
28.36 2.30 
Sterile alpha and TIR motif containing 
1 
30.36 30.18 30.00 
30.18 0.18 
Single immunoglobulin and toll-
interleukin 1 receptor (TIR) domain 
35.00 35.00 35.00 
35.00 0.00 
TGF-beta activated kinase 1/MAP3K7 
binding protein 1 
30.90 28.80 26.70 
28.80 2.10 
TANK-binding kinase 1 30.75 26.52 28.63 28.63 2.12 
Toll-like receptor adaptor molecule 1 30.41 29.21 28.01 29.21 1.20 
Toll-like receptor adaptor molecule 2 29.86 27.66 25.46 27.66 2.20 
Toll-interleukin 1 receptor (TIR) 
domain containing adaptor protein 
33.38 31.08 28.78 
31.08 2.30 
Toll-like receptor 1 34.94 34.93 34.92 34.93 0.01 
Toll-like receptor 10 35.00 35.00 35.00 35.00 0.00 
Toll-like receptor 2 30.90 31.90 32.90 31.90 1.00 
Toll-like receptor 3 34.96 32.85 30.74 32.85 2.11 
Toll-like receptor 4 35.00 35.00 35.00 35.00 0.00 
Toll-like receptor 5 35.00 35.00 35.00 35.00 0.00 
Toll-like receptor 6 30.50 30.61 30.72 30.61 0.11 
Toll-like receptor 7 35.00 35.00 35.00 35.00 0.00 
Toll-like receptor 8 35.00 35.00 35.00 35.00 0.00 
Toll-like receptor 9 35.00 35.00 35.00 35.00 0.00 
Tumor necrosis factor 35.00 35.00 35.00 35.00 0.00 
Tumor necrosis factor receptor 
superfamily, member 1A 
28.22 26.11 24.00 
26.11 2.11 
Toll interacting protein 29.91 28.71 27.51 28.71 1.20 
TNF receptor-associated factor 6 30.91 29.76 28.61 29.76 1.15 
Ubiquitin-conjugating enzyme E2N 29.87 26.47 23.07 26.47 3.40 
Actin, beta 20.67 19.34 18.01 19.34 1.33 
Beta-2-microglobulin 26.97 23.64 20.31 23.64 3.33 
Glyceraldehyde-3-phosphate 
dehydrogenase 




29.50 28.35 27.20 
28.35 1.15 
Ribosomal protein, large, P0 20.88 20.77 20.66 20.77 0.11 
Human Genomic DNA Contamination 35.00 35.00 35.00 35.00 0.00 
Reverse Transcription Control 30.47 28.24 26.01 28.24 2.23 
xxiii 
 
Reverse Transcription Control 31.37 28.19 25.01 28.19 3.18 
Reverse Transcription Control 29.73 28.37 27.01 28.37 1.36 
Positive PCR Control 23.00 23.80 24.60 23.80 0.80 
Positive PCR Control 23.69 23.01 24.38 23.69 0.69 
Positive PCR Control 23.00 23.84 24.68 23.84 0.84 
 








Table A2: Ct values of genes examined using PCR array analysis for H2S-treated 
periodontal fibroblasts. 







3 AVE SD 
      
Bruton agammaglobulinemia tyrosine 
kinase 
35.00 35.00 35.00 
35.00 0.00 
Caspase 8, apoptosis-related cysteine 
peptidase 
30.29 30.17 30.05 
30.17 0.12 
Chemokine (C-C motif) ligand 2 31.78 32.88 30.68 31.78 1.10 
CD14 molecule 33.39 34.49 32.29 33.39 1.10 
CD180 molecule 35.00 35.00 35.00 35.00 0.00 
CD80 molecule 35.00 35.00 35.00 35.00 0.00 
CD86 molecule 35.00 35.00 35.00 35.00 0.00 
Conserved helix-loop-helix ubiquitous 
kinase 
29.49 30.62 28.36 
29.49 1.13 
C-type lectin domain family 4, member 
E 
35.00 35.00 35.00 
35.00 0.00 
Colony stimulating factor 2 
(granulocyte-macrophage) 
33.65 31.53 29.41 
31.53 2.12 
Colony stimulating factor 3 
(granulocyte) 
35.00 35.00 35.00 
35.00 0.00 
Chemokine (C-X-C motif) ligand 10 35.00 35.00 35.00 35.00 0.00 
ECSIT homolog (Drosophila) 30.99 28.88 26.77 28.88 2.11 
Eukaryotic translation initiation factor 
2-alpha kinase 2 
28.55 27.40 26.25 
27.40 1.15 
ELK1, member of ETS oncogene 
family 
31.50 29.40 27.30 
29.40 2.10 
Fas (TNFRSF6)-associated via death 
domain 
29.89 27.79 25.69 
27.79 2.10 
FBJ murine osteosarcoma viral 
oncogene homolog 
34.28 32.28 30.28 
32.28 2.00 
High mobility group box 1 27.39 25.27 23.15 25.27 2.12 
V-Ha-ras Harvey rat sarcoma viral 
oncogene homolog 
29.48 27.43 25.38 
27.43 2.05 
Heat shock 70kDa protein 1A 30.93 27.92 24.91 27.92 3.01 
Heat shock 60kDa protein 1 
(chaperonin) 
26.67 24.34 22.01 
24.34 2.33 
Interferon, alpha 1 34.46 32.23 30.00 32.23 2.23 
Interferon, beta 1, fibroblast 35.00 35.00 35.00 35.00 0.00 
Interferon, gamma 35.00 35.00 35.00 35.00 0.00 
Inhibitor of kappa light polypeptide 
gene enhancer in B-cells, kinase beta 
30.43 29.32 28.21 
29.32 1.11 
Interleukin 10 35.00 35.00 35.00 35.00 0.00 
Interleukin 12A (natural killer cell 
stimulatory factor 1, cytotoxic 
lymphocyte maturation factor 1, p35) 
33.00 31.89 30.78 
31.89 1.11 
Interleukin 1, alpha 34.16 34.16 34.16 34.16 0.00 
xxv 
 
Interleukin 1, beta 35.00 35.00 35.00 35.00 0.00 
Interleukin 2 35.00 35.00 35.00 35.00 0.00 
Interleukin 6 (interferon, beta 2) 30.42 29.42 28.42 29.42 1.00 
Interleukin 8 25.68 24.56 23.44 24.56 1.12 
Interleukin-1 receptor-associated 
kinase 1 








30.89 28.78 26.67 
28.78 2.11 
Interferon regulatory factor 1 32.73 29.62 26.51 29.62 3.11 
Interferon regulatory factor 3 29.13 27.10 25.08 27.10 2.03 
Jun proto-oncogene 27.00 27.01 27.00 27.00 0.01 
Lymphotoxin alpha (TNF superfamily, 
member 1) 
34.93 34.94 34.92 
34.93 0.01 
Lymphocyte antigen 86 35.00 35.00 35.00 35.00 0.00 
Lymphocyte antigen 96 30.22 28.00 29.11 29.11 1.11 
Mitogen-activated protein kinase 
kinase 3 
27.80 25.40 23.00 
25.40 2.40 
Mitogen-activated protein kinase 
kinase 4 
29.66 28.56 27.46 
28.56 1.10 
Mitogen-activated protein kinase 
kinase kinase 1 
34.02 33.01 32.00 
33.01 1.01 
Mitogen-activated protein kinase 
kinase kinase 7 
28.95 26.84 24.73 
26.84 2.11 
Mitogen-activated protein kinase 
kinase kinase kinase 4 
28.40 26.20 24.00 
26.20 2.20 
Mitogen-activated protein kinase 8 29.44 28.22 27.00 28.22 1.22 
Mitogen-activated protein kinase 8 
interacting protein 3 
33.00 30.00 27.00 
30.00 3.00 
Myeloid differentiation primary 
response gene (88) 
29.27 28.15 27.03 
28.15 1.12 
Nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 1 
31.43 29.22 27.01 
29.22 2.21 
Nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 2 
(p49/p100) 
29.53 28.40 27.30 
28.41 1.11 
Nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 
inhibitor, alpha 
28.99 26.95 24.91 
26.95 2.04 
Nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 
inhibitor-like 1 
30.99 28.99 26.99 
28.99 2.00 
Nuclear factor related to kappaB 
binding protein 
33.49 30.49 27.49 
30.49 3.00 
Nuclear receptor subfamily 2, group C, 
member 2 
26.61 29.65 32.69 
29.65 3.04 
Pellino homolog 1 (Drosophila) 32.48 30.37 28.26 30.37 2.11 
Peroxisome proliferator-activated 
receptor alpha 




Protein kinase, interferon-inducible 
double stranded RNA dependent 
activator 
30.47 28.36 26.25 
28.36 2.11 
Prostaglandin-endoperoxide synthase 2 
(prostaglandin G/H synthase and 
cyclooxygenase) 
30.68 29.57 28.46 
29.57 1.11 
V-rel reticuloendotheliosis viral 
oncogene homolog (avian) 
33.90 30.80 27.70 
30.80 3.10 
V-rel reticuloendotheliosis viral 
oncogene homolog A (avian) 




29.61 27.48 25.37 
27.49 2.12 
Sterile alpha and TIR motif containing 
1 
31.62 30.52 29.42 
30.52 1.10 
Single immunoglobulin and toll-
interleukin 1 receptor (TIR) domain 
35.00 35.00 35.00 
35.00 0.00 
TGF-beta activated kinase 1/MAP3K7 
binding protein 1 
30.07 29.02 27.97 
29.02 1.05 
TANK-binding kinase 1 30.45 28.23 26.01 28.23 2.22 
Toll-like receptor adaptor molecule 1 30.25 29.15 28.05 29.15 1.10 
Toll-like receptor adaptor molecule 2 29.06 28.03 27.00 28.03 1.03 
Toll-interleukin 1 receptor (TIR) 
domain containing adaptor protein 
34.96 31.74 28.52 
31.74 3.22 
Toll-like receptor 1 34.20 34.20 34.20 34.20 0.00 
Toll-like receptor 10 35.00 35.00 35.00 35.00 0.00 
Toll-like receptor 2 30.70 31.95 33.04 31.90 1.17 
Toll-like receptor 3 30.54 32.65 34.76 32.65 2.11 
Toll-like receptor 4 35.00 35.00 35.00 35.00 0.00 
Toll-like receptor 5 35.00 35.00 35.00 35.00 0.00 
Toll-like receptor 6 32.70 30.70 28.70 30.70 2.00 
Toll-like receptor 7 35.00 35.00 35.00 35.00 0.00 
Toll-like receptor 8 35.00 35.00 35.00 35.00 0.00 
Toll-like receptor 9 35.00 35.00 35.00 35.00 0.00 
Tumor necrosis factor 35.00 35.00 35.00 35.00 0.00 
Tumor necrosis factor receptor 
superfamily, member 1A 
28.00 25.98 23.96 
25.98 2.02 
Toll interacting protein 29.92 28.81 27.70 28.81 1.11 
TNF receptor-associated factor 6 30.60 29.50 28.40 29.50 1.10 
Ubiquitin-conjugating enzyme E2N 27.64 26.32 25.00 26.32 1.32 
Actin, beta 20.56 19.45 18.34 19.45 1.11 
Beta-2-microglobulin 26.48 23.37 20.26 23.37 3.11 
Glyceraldehyde-3-phosphate 
dehydrogenase 




30.33 28.17 26.01 
28.17 2.16 
Ribosomal protein, large, P0 20.00 20.63 21.26 20.63 0.63 
Human Genomic DNA Contamination 35.00 35.00 35.00 35.00 0.00 
Reverse Transcription Control 30.91 28.51 26.11 28.51 2.40 
Reverse Transcription Control 29.88 28.76 27.64 28.76 1.12 
xxvii 
 
Reverse Transcription Control 31.72 25.47 28.59 28.60 3.13 
Positive PCR Control 24.81 23.63 22.43 23.62 1.19 
Positive PCR Control 25.79 23.68 21.57 23.68 2.11 
Positive PCR Control 26.92 23.92 20.92 23.92 3.00 
 









Table A3: Average ΔCt values, 2^-ΔCt and fold change of genes examined using 
PCR array analysis between control and NaHS-treated periodontal fibroblasts. 
Toll-like receptor signalling 
PCR array 
 




















12.46 12.50 0.00 0.00 1.00 
Caspase 8, apoptosis-related 
cysteine peptidase 
7.63 7.55 0.01 0.01 0.94 
Chemokine (C-C motif) ligand 
2 
9.25 9.30 0.00 0.00 1.02 
CD14 molecule 10.86 10.67 0.00 0.00 0.88 
CD180 molecule 12.46 12.50 0.00 0.00 1.00 
CD80 molecule 12.46 12.50 0.00 0.00 1.00 
CD86 molecule 12.46 12.50 0.00 0.00 1.00 
Conserved helix-loop-helix 
ubiquitous kinase 
6.95 6.93 0.01 0.01 0.98 
C-type lectin domain family 4, 
member E 
12.46 12.50 0.00 0.00 1.00 
Colony stimulating factor 2 
(granulocyte-macrophage) 9.03 
12.50 0.00 0.00 
11.09 
Colony stimulating factor 3 
(granulocyte) 
12.46 12.50 0.00 0.00 1.00 
Chemokine (C-X-C motif) 
ligand 10 
12.46 12.50 0.00 0.00 1.00 
ECSIT homolog (Drosophila) 6.35 6.33 0.01 0.01 0.99 
Eukaryotic translation 
initiation factor 2-alpha kinase 
2 
4.87 4.90 0.03 0.03 1.00 
ELK1, member of ETS 
oncogene family 
6.86 6.79 0.01 0.01 0.95 
Fas (TNFRSF6)-associated via 
death domain 
5.26 4.86 0.03 0.03 0.76 
FBJ murine osteosarcoma viral 
oncogene homolog 
9.78 10.75 0.00 0.00 1.96 
High mobility group box 1 2.74 2.68 0.15 0.16 0.96 
V-Ha-ras Harvey rat sarcoma 
viral oncogene homolog 
4.89 4.99 0.03 0.03 1.05 
Heat shock 70kDa protein 1A 5.38 4.99 0.02 0.03 0.77 
Heat shock 60kDa protein 1 
(chaperonin) 
1.80 1.83 0.29 0.28 1.00 
Interferon, alpha 1 9.73 12.50 0.00 0.00 6.81 
Interferon, beta 1, fibroblast 12.46 12.50 0.00 0.00 1.00 
Interferon, gamma 12.46 12.50 0.00 0.00 1.00 
Inhibitor of kappa light 6.82 7.14 0.01 0.01 1.25 
xxix 
 
polypeptide gene enhancer in 
B-cells, kinase beta 
Interleukin 10 12.46 12.50 0.00 0.00 1.00 
Interleukin 12A (natural killer 
cell stimulatory factor 1, 
cytotoxic lymphocyte 
maturation factor 1, p35) 
9.39 11.19 0.00 0.00 
3.49 
Interleukin 1, alpha 11.62 11.29 0.00 0.00 0.79 
Interleukin 1, beta 12.46 12.50 0.00 0.00 1.00 
Interleukin 2 12.46 12.50 0.00 0.00 1.00 
Interleukin 6 (interferon, beta 
2) 
6.96 10.33 0.01 0.00 
10.68 
Interleukin 8 2.06 6.35 0.24 0.01 19.66 
Interleukin-1 receptor-
associated kinase 1 
6.61 6.07 0.01 0.01 0.69 
Interleukin-1 receptor-
associated kinase 2 
7.09 7.31 0.01 0.01 1.16 
Interleukin-1 receptor-
associated kinase 4 
6.24 5.89 0.01 0.02 0.79 
Interferon regulatory factor 1 7.09 7.31 0.01 0.01 1.14 
Interferon regulatory factor 3 4.56 4.68 0.04 0.04 1.06 
Jun proto-oncogene 4.49 4.83 0.04 0.04 1.26 
Lymphotoxin alpha (TNF 
superfamily, member 1) 
12.39 12.50 0.00 0.00 1.05 
Lymphocyte antigen 86 12.46 12.50 0.00 0.00 1.00 
Lymphocyte antigen 96 6.58 6.74 0.01 0.01 1.10 
Mitogen-activated protein 
kinase kinase 3 
2.89 4.53 0.14 0.04 
3.09 
Mitogen-activated protein 
kinase kinase 4 
6.02 6.34 0.02 0.01 1.22 
Mitogen-activated protein 
kinase kinase kinase 1 
10.48 9.60 0.00 0.00 0.55 
Mitogen-activated protein 
kinase kinase kinase 7 
4.34 4.56 0.05 0.04 1.17 
Mitogen-activated protein 
kinase kinase kinase kinase 4 
3.68 3.91 0.08 0.07 1.16 
Mitogen-activated protein 
kinase 8 
5.69 6.07 0.02 0.01 1.27 
Mitogen-activated protein 
kinase 8 interacting protein 3 
7.47 7.35 0.01 0.01 0.92 
Myeloid differentiation 
primary response gene (88) 
5.61 5.50 0.02 0.02 0.93 
Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells 1 
6.68 6.89 0.01 0.01 1.13 
Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells 2 (p49/p100) 
5.87 6.57 0.02 0.01 1.59 
Nuclear factor of kappa light 
polypeptide gene enhancer in 
4.41 4.47 0.05 0.05 1.01 
xxx 
 
B-cells inhibitor, alpha 
Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells inhibitor-like 1 
6.49 5.70 0.01 0.02 0.58 
Nuclear factor related to 
kappaB binding protein 
7.96 7.88 0.00 0.00 0.95 
Nuclear receptor subfamily 2, 
group C, member 2 
7.11 7.02 0.01 0.01 0.94 
Pellino homolog 1 
(Drosophila) 
7.84 8.22 0.00 0.00 1.27 
Peroxisome proliferator-
activated receptor alpha 
6.52 6.53 0.01 0.01 1.00 
Protein kinase, interferon-
inducible double stranded 
RNA dependent activator 
5.83 5.73 0.02 0.02 0.93 
Prostaglandin-endoperoxide 
synthase 2 (prostaglandin G/H 
synthase and cyclooxygenase) 
7.07 7.77 0.01 0.00 
1.61 
V-rel reticuloendotheliosis 
viral oncogene homolog 
(avian) 
8.27 8.77 0.00 0.00 1.38 
V-rel reticuloendotheliosis 
viral oncogene homolog A 
(avian) 
4.51 4.92 0.04 0.03 1.30 
Receptor-interacting serine-
threonine kinase 2 
4.98 5.86 0.03 0.02 1.84 
Sterile alpha and TIR motif 
containing 1 
7.98 7.68 0.00 0.00 0.81 
Single immunoglobulin and 
toll-interleukin 1 receptor 
(TIR) domain 
12.46 12.50 0.00 0.00 1.00 
TGF-beta activated kinase 
1/MAP3K7 binding protein 1 
6.49 6.30 0.01 0.01 0.88 
TANK-binding kinase 1 5.69 6.12 0.02 0.01 1.32 
Toll-like receptor adaptor 
molecule 1 
6.65 6.70 0.01 0.01 1.04 
Toll-like receptor adaptor 
molecule 2 
5.49 5.15 0.02 0.03 0.79 
Toll-interleukin 1 receptor 
(TIR) domain containing 
adaptor protein 
9.20 8.58 0.00 0.00 0.65 
Toll-like receptor 1 11.66 12.43 0.00 0.00 1.66 
Toll-like receptor 10 12.46 12.50 0.00 0.00 1.00 
Toll-like receptor 2 9.39 9.34 0.00 0.00 0.97 
Toll-like receptor 3 10.11 10.34 0.00 0.00 1.15 
Toll-like receptor 4 12.46 12.50 0.00 0.00 1.00 
Toll-like receptor 5 12.46 12.50 0.00 0.00 1.00 
Toll-like receptor 6 8.16 8.11 0.00 0.00 0.96 
Toll-like receptor 7 12.46 12.50 0.00 0.00 1.00 
Toll-like receptor 8 12.46 12.50 0.00 0.00 1.00 
xxxi 
 
Toll-like receptor 9 12.46 12.50 0.00 0.00 1.00 
Tumor necrosis factor 12.46 12.50 0.00 0.00 1.00 
Tumor necrosis factor receptor 
superfamily, member 1A 
3.44 3.60 0.09 0.08 1.10 
Toll interacting protein 6.28 6.21 0.01 0.01 0.95 
TNF receptor-associated factor 
6 
7.00 7.25 0.01 0.01 1.17 
Ubiquitin-conjugating enzyme 
E2N 
3.79 3.97 0.07 0.06 
1.11 
  
 
